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Abstract 
The thymus generates central immune tolerance by producing self-restricted and self-
tolerant T-cells as a result of interactions between developing thymocytes and thymic epithelial 
cells (TECs). While the functional importance of TECs is well established, the mechanisms that 
direct their embryonic development are unclear. The Notch pathway is a major signaling 
pathway involved in cell-fate determination. Recently, H. Neves group observed that, during 
chicken embryogenesis, Notch signaling-related molecules are expressed in the endoderm of 
the pharyngeal pouches, prior to their specification into TECs, suggesting the involvement of 
Notch signaling in this process. In this work we aimed to study the role of Notch signaling in 
early stages of thymic development in chicken. 
To modulate Notch signaling in vivo, two new plasmids were generated with either the 
constitutively active form of Notch1 (intracellular domain of Notch1, ICN1) (pT2K-
ICN1eGFP), or the dominant-negative (DN) form of Mastermind-like1 (MAML1) 
(transcriptional co-activator Notch signaling) (pT2K-DNMAML1eGFP). pT2K-ICN1eGFP and  
pT2K-DNMAML1eGFP were integrated in a “Tol2-mediated gene transfer” and “Tet-On” 
combined system of vectors developed by Y. Takahashi and collaborators, allowing the study 
of gain- and loss-of-function of Notch signaling, respectively. Our results show that pT2K-
DNMAML1eGFP plasmid in this system, is capable of blocking Notch signaling. Conversely, 
further assays are required to confirm the functionality of pT2K-ICN1eGFP plasmid. Future 
studies of gain- and loss-of-function of Notch signaling in early thymic development will be 
performed by the genetic modification of isolated endodermal tissues of the presumptive 
territory of TECs with this system. The manipulated tissues will then be grafted into the body 
wall of a chicken embryo and thymic development followed by in situ observation. 
In vitro assays of pharyngeal region explants of E3.5 and E4 chicken embryos were 
performed to study the effect of Notch signaling inhibition during epithelial-mesenchymal 
interactions in early thymic development.  Thymus and parathyroid glands development was 
assessed by Foxn1 and Gcm2 expression, respectively. We observed that Notch signaling 
inhibition by a γ-Secretase inhibitor (DAPT) interferes in Foxn1 expression in an apparent 
random fashion, making inconclusive its role in early thymic development. On the other hand, 
Gcm2 expression is down-regulated when Notch signaling is inhibited. This data suggests that 
Notch signaling is required in early stages of parathyroid development.  Further studies are 
essential to unravel the role of Notch signaling in early thymic development.  
 
Keywords: Notch, thymus, thymic epithelial cells, pharyngeal pouch, endoderm, Foxn1 
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Resumo 
O timo gera tolerância imunitária ao produzir células-T “auto-restritas” e “auto-
tolerantes”, cuja geração depende das interacções das suas células precursoras, os timócitos, 
com células especializadas do nicho tímico, as células epiteliais tímicas (CET). Embora a 
importância funcional das CET esteja bem estabelecida, os mecanismos moleculares 
responsáveis pelo seu desenvolvimento embrionário são ainda desconhecidos. O 
desenvolvimento do timo é acompanhado de perto pelo desenvolvimento das glândulas 
paratireóides. Os domínios presuntivos do timo e das glândulas paratireóides foram 
identificados na endoderme da 3ª e 4ª bolsas faríngicas pela expressão de Foxn1 e Gcm2, 
respectivamente. A especificação das CET depende de interacções entre a endoderme da 3ª e 4ª 
bolsas faríngicas e o mesênquima circundante - interacções epitélio-mesenquimais. Algumas 
destas interacções epitélio-mesenquimais começam agora a ser reveladas, nomeadamente 
através do trabalho do grupo de H. Neves, que demonstra que factores de transcrição como o 
Bmp4 e o Fgf10 são expressos sequencialmente no mesênquima e são essenciais para a 
especificação da endoderme da 3ª e 4ª bolsas faríngicas em CET. Outras vias de sinalização têm 
sido sugeridas como prováveis intervenientes neste processo. A sinalização Notch é uma delas, 
sendo uma via altamente conservada no reino animal, envolvida nos processos de decisão do 
destino celular, no desenvolvimento embrionário e no adulto. Esta via de sinalização regula 
vários processos biológicos, incluindo a hematopoiese, miogénese, neurogénese, 
vasculogénese, desenvolvimento da pele e outros processos de organogénese. 
Em 2001, o grupo de L. Parreira descreveu pela primeira vez, num contexto de um 
nicho estromal, a importância da formação de um microambiente Notch para a correcta 
especificação de progenitores hematopoiéticos nas diferentes linhagens linfóides. Este e outros 
grupos também observaram que os genes envolvidos na sinalização Notch são expressos de 
forma distinta nos diferentes territórios do timo adulto, reforçando a importância desta via de 
sinalização na função do mesmo. Recentemente, o grupo de H. Neves também observou, em 
embriões de galinha, que os genes envolvidos na sinalização Notch (receptores, ligandos e 
genes-alvo) estão diferencialmente expressos na endoderme das bolsas faríngicas, em estádios 
prévios à formação do rudimento tímico. Também observaram, usando um novo sistema in 
vitro de associações heteroespecíficas de tecidos embrionários, que a sinalização Notch 
interfere com a expressão normal de Foxn1 (marcador de CET) na endoderme das bolsas 
faríngicas. Este sistema de cultura permite uma análise funcional das moléculas envolvidas nas 
interacções epitélio-mesenquimais e também determinar a dinâmica temporal destas moléculas 
durante o desenvolvimento do timo. Este sistema recapitula in vitro os acontecimentos precoces 
do desenvolvimento tímico in vivo, uma vez que, quando enxertadas na membrana 
corioalantóide do embrião de galinha, estas associações de tecidos desenvolvem um timo 
funcional. Estes dados sugerem que a sinalização Notch está envolvida na especificação da 
endoderme das bolsas faríngicas em epitélio tímico.  
Neste projecto, tivemos como objectivo estudar a sinalização Notch na especificação da 
endoderme das bolsas faríngicas em epitélio tímico. Para isso, desenvolvemos estratégias in 
vivo e in vitro de ganho e perda-de-função da sinalização Notch em embriões de galinha. Para a 
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abordagem in vivo, dois plasmídeos novos foram construídos, para expressar a forma 
constitutivamente activa de Notch1 (domínio intracelular de Notch1, ICN1) (pT2K-ICN1eGFP) 
ou a forma dominante-negativa de Mastermind-like1 (MAML1) (co-activador transcricional de 
sinalização Notch) (DNMAML1) (pT2K-DNMAML1eGFP). Estes plasmídeos foram 
integrados num sistema de vectores desenvolvido por Y. Takahashi e colaboradores, que 
combina a “transferência génica mediada por Tol2” e a “expressão condicional dependente de 
tetraciclina”. Assim, este sistema de vectores oferece uma abordagem experimental única para 
uma análise temporal, e específica de tecido, dos efeitos de ganho e perda-de-função da 
sinalização Notch durante a especificação/diferenciação das CET. Para realizar esses estudos, 
células endodérmicas do território gerador do epitélio tímico serão modificadas geneticamente 
com os plasmídeos pT2K-ICN1eGFP ou pT2K-DNMAML1eGFP (neste sistema de vectores) 
para activar ou bloquear a sinalização Notch, respectivamente, e serão enxertadas na parede do 
embrião de galinha, para acompanhar in situ o desenvolvimento do timo quimérico. Os nossos 
resultados mostram que o plasmídeo que expressa a forma DNMAML1, pT2K-
DNMAML1eGFP, neste sistema de vectores, tem a capacidade de inibir a sinalização Notch. O 
trabalho poderá assim prosseguir para os estudos de perda-de-função da sinalização Notch na 
endoderme das bolsas faríngicas, antes da sua especificação em CET. Por outro lado, o 
plasmídeo que expressa o ICN1, pT2K-ICN1eGFP, neste sistema de vectores, necessita de mais 
experimentação para comprovar a sua funcionalidade. 
A abordagem in vitro consistiu na realização de ensaios de cultura de explantes da 
região faríngica de embriões de galinha com 3.5 e 4 dias de desenvolvimento para estudar o 
efeito da inibição farmacológica da sinalização Notch (com um inibidor da γ-Secretase – 
DAPT) durante as interacções epitélio-mesenquimais no desenvolvimento inicial do timo. 
Tanto a especificação da endoderme faríngica em epitélio tímico como a manutenção do 
domínio das glândulas paratireóides nos explantes em cultura foram avaliadas através da 
expressão in situ de Foxn1 e Gcm2, respectivamente. Os nossos ensaios in vitro revelaram que 
a inibição da sinalização Notch, em fases iniciais do desenvolvimento tímico, interfere com a 
expressão de Foxn1 de forma aparentemente aleatória, mostrando elevada heterogeneidade de 
resultados. Assim, o papel da sinalização Notch em fases iniciais do desenvolvimento do timo 
continua por precisar. Por outro lado, a expressão de Gcm2 é bloqueada com a inibição da 
sinalização Notch nessas mesmas fases de desenvolvimento. Portanto, os nossos dados in vitro 
sugerem um papel da sinalização Notch no desenvolvimento das glândulas paratireóides, pelo 
menos em fases iniciais do desenvolvimento. 
Novas experiências in vitro usando explantes da região faríngica de embriões de galinha 
em estádios de desenvolvimento diferentes (tanto mais precoces como mais tardios) daqueles 
estudados, e a realização dos estudos in vivo com o nosso sistema de vectores, serão essenciais 
para compreender estes resultados e também para estudar o papel da sinalização Notch na 
especificação/desenvolvimento das CET.  
 
Com este projecto esperamos contribuir para o conhecimento do papel da sinalização 
Notch no desenvolvimento normal das células epiteliais tímicas, um passo fundamental na 
compreensão dos eventos responsáveis pela manutenção de um timo saudável ao longo da vida 
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e pela reparação da sua função em situações patológicas. Mais, o conhecimento de elementos 
chave envolvidos na especificação das CET poderá no futuro permitir a criação de novos 
sistemas in vitro para gerar células epiteliais tímicas, as quais, por sua vez, poderão abrir novas 
possibilidades de produção in vitro de repertórios de células-T e novas oportunidades para 
restaurar a função tímica em indivíduos atímicos ou imunodeficientes e, também, melhorar as 
terapias de transplantação de órgãos. 
 
Palavras-chave: Notch, timo, células epiteliais tímicas, bolsa faríngica, endoderme, Foxn1 
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I. Introduction 
I.1. Thymus Development  
The thymus is a specialized organ of the adaptive immune system, responsible for the 
development of thymocytes into T lymphocytes. This organ is found in all jawed vertebrates 
and co-evolved with VDJ recombination mechanism which is used to somatically diversify 
antigen receptors (Thomas Boehm & Bleul, 2007).  Although its existence was known for 
centuries, its immunologic function was only discovered in 1961 by Jacques Miller, when he 
observed a deficit in a specific type of lymphocytes (later called T-lymphocytes), after 
performing thymectomies in mice (Miller, 1961).  
 Thymus organogenesis is a highly dynamic process that is initiated during fetal life and 
can be divided in two main temporal phases; an initial thymocyte-independent phase, where 
cellular interactions between the endoderm and the surrounding mesenchyme direct thymic 
epithelial cells (TECs) specification, followed by a thymocyte-dependent phase. At this latter 
stage, the thymic enlagen depends on the colonization by lymphoid progenitor cells (LPCs) for 
further maturation of thymic epithelium into cortical (cTECs) and medullar (mTECs) 
compartments (Alves, Huntington, Rodewald, & Di Santo, 2009; G Anderson & E J Jenkinson, 
2001; Auerbach, 1960; C Clare Blackburn & Nancy R Manley, 2004; N M Le Douarin, 
Dieterlen-Lièvre, & Oliver, 1984; Klug, Carter, Gimenez-Conti, & Richie, 2002; Nehls et al., 
1996). 
TECs are a specialized subset of thymic cells required for all stages of thymocyte 
differentiation (Anderson et al. 1993; Anderson, Owen, Moore, & Jenkinson, 1994; 
Oosterwegel et al. 1997; Klug et al. 1998; Ge & Chen, 2000; Bennett et al. 2002); specific 
TECs subtypes mediate particular aspects of thymopoiesis: cTECs are involved in positive 
selection (Cosgrove, Chan, Waltzinger, Benoist, & Mathis, 1992) and mTECs in tolerance 
induction (Gotter, Brors, Hergenhahn, & Bruno Kyewski, 2004).  
In 1975, Le Douarin & Jotereau, using the chick–quail chimera system, showed that 
TECs derive from the pharyngeal pouches (PP) endoderm (N M Le Douarin & Jotereau, 1975). 
This single, endodermal germ layer origin, of the thymic epithelium was further supported by 
other studies in mouse (Bleul et al., 2006; Rossi, W. E. Jenkinson, Graham Anderson, & Eric J 
Jenkinson, 2006).  
Thymic epithelium development is intimately linked to the development of the 
parathyroid glands, as their rudiments derive from the common embryonic structure of the PP 
[3rd and 4th PP (3/4PP) in chicken and humans, 3rd PP in mouse]. The pharyngeal pouches are 
bilateral transient structures that arise as outpocketings of the lateral foregut endoderm. The PP, 
along with the opposing pharyngeal clefts (PC) (invaginations of surface ectoderm) form the 
separation between pharyngeal arches (PA), the bilateral bulges that comprise the pharyngeal 
region (Fig. 1) (J. Gordon & N. R. Manley, 2011; Patel, Julie Gordon, Mahbub, C Clare 
Blackburn, & Nancy R Manley, 2006; Rodewald, 2008).  
In the mouse, the prospective thymic epithelium was identified by the expression of 
Foxn1 (forkhead box N1) transcription factor (J Gordon, Bennett, C C Blackburn, & N R 
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Manley, 2001), a product of the nude locus, which is required cell-autonomously for thymic 
epithelium differentiation and colonization by LPCs (Nehls et al., 1996; C C Blackburn et al., 
1996; Bleul et al., 2006). The parathyroid rudiment was defined by the expression of Gcm2 
(Glial Cell Missing 2) transcription factor (J Gordon et al., 2001); when Gcm2 is deleted, no 
parathyroid glands are formed (Günther et al., 2000; Z. Liu, Yu, & Nancy R Manley, 2007).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Scheme representing coronal section through the pharyngeal zone. Pharyngeal arches, consist 
of mesenchymal and mesodermal cells bounded by an outer layer of surface ectoderm (blue) and inner layer 
of pharyngeal endoderm (yellow). The ectoderm forms invaginations, the pharyngeal clefts, which separate 
the arches, whereas the endoderm forms the opposing outpocketings, the pharyngeal pouches. 
In chicken, the transcription factors Foxn1 and Gcm2 are also expressed in the 
endodermal rudiments of the thymus and parathyroid glands, respectively.  Specifically, Foxn1 
domain of expression was identified as the emergent domain of thymic epithelium in the most 
dorsal portion of the 3/4 PP endoderm in chicken embryo at E4.5 (Fig. 2A and B) (Neves et al., 
2011 in press). Conversely, parathyroid rudiments were identified in a more ventral position in 
the 3/4 PP by Gcm2 domain of expression (Fig. 2B) (Neves et al., 2011 in press). 
The initial phase of thymic organogenesis is characterized by cellular interactions 
between the endoderm and the surrounding neural crest-derived mesenchyme to TECs 
specification (Rodewald, 2008). The importance of epithelial-mesenchymal interactions was 
demonstrated by Le Douarin, using the chick-quail chimera system. The 3/4PP endoderm 
isolated from early quail embryos was able to develop into thymic epithelium with the 
cooperation of a heterologous mesenchyme such as the somatopleure or splanchnopleure of E3 
chicken embryos, which thus could be considered “permissive” to endoderm development. 
Furthermore, the grafted endoderm was capable of inducing the heterologous mesenchyme to 
participate in the formation of a fully developed thymus (N. Le Douarin, 1967; Le Douarin, N., 
Bussonnet, C., Chaumont, 1968; N. M. Le Douarin & Jotereau, 1975). In contrast, 
mesenchymal environments of the somite and limb bud were non-permissive to 3/4PP 
endoderm development (N. Le Douarin, 1967; Le Douarin, N., Bussonnet, C., Chaumont, 
1968). These data provided the first evidence that epithelial-mesenchymal reciprocal 
interactions are essential for early thymic development; moreover, they revealed that some 
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heterologous mesenchymal tissues are able to mimic the role played by neural crest-derived 
mesenchyme during normal development of the thymus in the pharyngeal region. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Expression of Foxn1 and Gcm2 during thymic and parathyroid glands development in chick 
embryos. A) In situ hybridization showing Foxn1 expression in PP3/4 endoderm isolated by microsurgery in 
E4.5 chicken embryos. B) Schematic 3D-representation of Foxn1 and Gcm2 expression domains in the 3
rd
 PP 
endoderm of E4.5 chicken embryos. (A, anterior; D, dorsal; c, chicken; P, posterior; PP, pharyngeal pouch; V, 
ventral). 
 
Recently, H. Neves work unraveled some of the early molecular events occurring at the 
initial thymocyte-independent stage of thymic development. Her results showed that cellular 
interactions between the endoderm and adjacent mesenchyme involved a sequential expression 
of Bmp4 and Fgf10 in the mesenchymal compartment,  fundamental for the development of the 
3/4PP endoderm into of thymic and parathyroid glands epithelia. Also, a temporal regulation of 
Bmp4 expression in the mesenchymal compartment was observed, suggesting that the Bmp4 
levels need to be tightly regulated in the developing pouches (Neves et al., 2011 in press). 
Another signaling pathway known to be involved in epithelial cell development 
(dependent on mesenchymal interactions) in other organs like the skin and the gut is Notch 
signaling (Hu et al., 2010; T.-H. Kim, B.-M. Kim, Mao, Rowan, & Shivdasani, 2011). 
 
 
I.2. Notch signaling 
Notch signaling is a major signaling-pathway, highly conserved in the animal kingdom, 
which regulates biological processes in the development of the embryo and in the adult. Notch 
signaling has been shown to control hematopoiesis (Jaleco et al. 2001; Neves et al. 2006; 
Santos et al. 2007; Parreira et al. 2003; Eric J Jenkinson et al. 2006), myogenesis (Luo, Renault, 
& Rando, 2005), neurogenesis (Lasky & H. Wu, 2005), vasculogenesis (L. M. Anderson & 
Gibbons, 2007), skin development (Estrach, Cordes, Hozumi, Gossler, & Watt, 2008) and other 
aspects of organogenesis. Notch receptors (Notch1-4 in mammals, Notch1-2 in birds) and their 
ligands (Delta1, 3 and 4; Jagged1-2 in mammals, Serrate1-2 in birds) are evolutionary 
conserved transmembrane proteins that regulate cell-fates, cell numbers and cell position via 
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effects on proliferation and survival (Lai, 2004). These effects depend on dose, timing, and 
context of the Notch signal (Lai, 2004; Maillard, Fang, & Pear, 2005). 
Notch-mediated transcriptional activation involves the activation of Notch receptors by 
their ligands that are expressed on neighboring cells. This receptor-ligand interaction will lead 
to the proteolytic cleavage of the intracellular domain of Notch (ICN), catalyzed by the γ-
secretase complex. Thus, the ICN is released from the membrane and is translocated into the 
nucleus, where it cooperates with the DNA-binding protein CSL and co-activators to form the 
transcriptional activation complex, which will activate target gene expression (W. R. Gordon, 
Arnett, & Stephen C Blacklow, 2008). One important co-activator is Mastermind-like (MAML) 
protein (L Wu et al., 2000), which appears to function as a scaffold for the formation of a large 
multiprotein transcriptional activation complex (Jeffries, Robbins, & Capobianco, 2002) (Fig. 
3). The Mastermind protein was originally identified in D. melanogaster as a neurogenic 
protein genetically linked to the Notch signaling pathway (Xu, Rebay, Fleming, Scottgale, & 
Artavanis-Tsakonas, 1990), and the mammalian homologues that were found afterwards were 
named Mastermind-like proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Schematic representation of Notch signaling pathway in chicken. Ligand (Serrate1,3 or 
Delta1,3,4) binding between neighboring cells induces proteolytic cleavage of Notch receptors (Notch1,2), 
catalyzed by the γ-secretase complex, producing the free intracellular domain of Notch (ICN). ICN 
translocates to the nucleus and binds to transcription factors, MAML1 being one of them. The transcription of 
Notch target genes (ex: Hairy1, Hes5-1 or Hes5-1) is then activated. 
 
It is known that, when a cell is forced to express the ICN, Notch signaling is 
constitutively active in a ligand independent manner (G Weinmaster, 1997). On the other hand, 
in vitro experiments in mice have shown that truncated MAML1 proteins consisting of only the 
N-terminal ICN-binding domain have potent dominant negative effects, presumably due to 
their inability to recruit other components of the Notch transcriptional activation complex 
(Fryer, Lamar, Turbachova, Kintner, & K. A. Jones, 2002; Weng et al., 2003). Thus, when a 
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cell is forced to express the dominant-negative (DN) form of MAML1 protein (DNMAML1), 
Notch signaling is profoundly blocked.  
The activation of the Notch signaling induces a profound alteration of the cellular 
transcriptional program. The best-characterized Notch targets are the Hes genes. Hes genes are 
mammalian homologs of the Drosophila genes Hairy and Enhancer of split, characterized by 
basic helix–loop–helix proteins. Hes genes were shown to contribute to clocks that regulate 
somitogenesis, limb segmentation, and neural progenitor maintenance (Brend & Holley, 2009; 
Lewis, Hanisch, & Holder, 2009; Pascoal et al., 2007; Shimojo, Ohtsuka, & Ryoichiro 
Kageyama, 2008). 
One of the first Hes genes described in vertebrates was a homologue of Drosophila 
hairy in mouse, which was given the name of Hes1 (Sasai, R Kageyama, Tagawa, Shigemoto, 
& Nakanishi, 1992). Hes1, in general, maintains cells in the undifferentiated progenitor state, 
influences progenitor cell proliferation and differentiation, specifically it inhibits neuronal and 
muscle differentiation ( Sasai et al., 1992; Ishibashi et al., 1994). Other Hes genes have been 
found over the time. Hes6 proteins are known to regulate neurogenesis by contributing to 
release differentiating neurons from Notch signaling (Vilas-Boas & Domingos Henrique, 
2010). Also, Hes6 has been shown to regulate muscle differentiation (Cossins, Vernon, Zhang, 
Philpott, & P. H. Jones, 2002). Furthermore,  Hes5-1 is known to be a direct target of Notch 
signaling in the developing nervous system; Hes5-1 transcription is severely reduced when 
Notch signaling is blocked (De La Pompa et al., 1997; Lütolf, Radtke, Aguet, Suter, & Taylor, 
2002) and its promoter is directly regulated by Notch (Nishimura et al., 1998). 
 
Previous work from L. Parreira and collaborators shown the importance of specific 
Notch microenvironments for the commitment of hematopoietic progenitors into different 
lymphoid lineages (Jaleco et al., 2001), for the expansion and lineage-differentiation of early-
myeloid progenitors (Neves et al., 2006) and for the generation of plasma cells and the amount 
of antibodies secreted by them, in terminal B-cell maturation (Santos et al., 2007). They also 
observed that Notch-related genes are differentially expressed in the adult thymic 
microenvironments, stressing the importance of this signaling pathway in thymic function 
(Jenkinson et al., 2006; Parreira et al., 2003).  
Notch signaling is known to play a role during late stages of thymic organogenesis. At 
the thymocyte-dependent phase, TECs provide Notch ligands to neighboring developing 
thymocytes, promoting their development (Alves, Goff, et al., 2009; Feyerabend et al., 2009; 
Hozumi et al., 2008; Koch et al., 2008; Tsukamoto, Itoi, Nishikawa, & Amagai, 2005). 
Specifically, Notch signaling activation mediated by Delta1 induced the appearance of a normal 
thymic architecture in murine fetal thymic organ cultures (Masuda et al., 2009). In contrast, 
only few evidences point to a role of Notch at early-phase of thymus formation. 
Preliminary results of H. Neves and collaborators suggest a role of Notch signaling 
during chicken thymus development. They observed Notch signaling-related genes (receptors, 
ligands and target genes) expressed in the prospective thymic domain and surrounding 
mesenchyme. In particular, the expression of Hes1, in the endoderm of the 3/4PP at E3 and E4, 
suggests active Notch signaling in the prospective territory of TECs. Furthermore, using a 
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novel in vitro system (developed by Neves & Le Douarin, 2009) to study early-stages of 
thymus development, they observed that blocking Notch signaling interferes with the normal 
expression of Foxn1 in the endoderm of the pharyngeal-pouches. This in vitro culture system, 
with heterospecific associations of embryonic tissues, allows the functional analysis of 
molecules involved in epithelial-mesenchymal interactions and to determine the temporal 
dynamics of those molecules during thymus development.  These heterospecific associations of 
embryonic tissues, when grafted in the chorioallantoic membrane of a chick embryo, develop 
into a functional thymus, showing the ability of this in vitro system to recapitulate the early 
events of thymic development in vivo. These observations suggest that Notch signaling is 
involved in the specification of TECs from the endoderm of 3/4PP.  
To investigate how Notch signaling affects early stages of thymus organogenesis we 
aim to modify in a stable and cell-autonomous manner the quail endodermal tissues of the 
presumptive territory of TECs. This tissue will be genetically modified to either express the 
constitutively-active form of Notch1 , ICN1,  or a dominant-negative form of MAML1, 
DNMAML1, using a “Tol2-mediated gene transfer” and “Tetracycline-dependent conditional 
expression” combined system of vectors. 
 
I.3. “Tol2-mediated gene transfer system” and “tetracycline-dependent 
conditional expression” system for the study of Notch signaling 
Y. Takahashi and collaborators developed a combined system of transposon-mediated 
transgene and tetracycline-induced conditional expression (Sato et al., 2007; Watanabe et al., 
2007). This system has the advantage of allowing a stable integration and a conditional 
expression of a transgene in chicken embryos. The original system is composed of three 
plasmids: 1) pT2K-CAGGS-rtTA2SM2; 2) pT2K-BI-TREeGFP and 3) pCAGGS-T2TP (Fig. 
1). Both 1 and 2 plasmids have a gene expression cassette surrounded by Tol2 transposable 
elements. After electroporation of the three plasmids, transient activity of transposase (plasmid 
3) will induce the transposon construct containing either rtTA2S-M2 (plasmid 1) or TRE-eGFP 
(plasmid 2) to be integrated into the host genome. The reverse tet-controlled transcriptional 
activator (rtTA) (plasmid 1), ubiquitously expressed by the promoter-CAGGS, acts on the cis-
element promoter, tetracycline responsive element (TRE). rtTA binds to TRE only in the 
presence of doxycycline (an analog of tetracycline; Dox) and activates transcription of the 
TRE-driven gene (“Tet-On expression system”). pT2K-BI-TREeGFP has a bidirectional TRE 
with two minimal promoters of cytomegalovirus in both directions. In one direction, it has an 
eGFP sequence and on the other one a polylinker region where one can clone the transgenes of 
interest (Fig. 4). Thus, this system allows stable integration of transgenes in the avian genome, 
which can be conditionally expressed in specific time-points of development, upon 
administration of Dox. Cells expressing the transgene will be identified by GFP expression, 
therefore the correlation between the time of Dox administration and GFP expression will 
determine the exact moment of transgene expression.   
As previously mentioned, the sequences coding for the ICN1, or for the DNMAML1, in 
fusion with GFP, were sub-clone into the pT2K-BI-TREeGFP plasmid, so that Notch signaling 
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can be constitutively activated or blocked, respectively, in a cell-autonomous manner. The 
reliability of the new constructs in activating or blocking Notch signaling was analyzed using 
the C2C12 myoblast differentiation assay. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. “Tol2-mediated gene transfer system” and “tetracycline-dependent conditional expression” 
combined system. Transient activity of transposase (pCAGGS-T2TP) will induce the transposon construct 
containing either rtTA2
S
-M2 (pT2K-CAGGS-rtTA2
S
M2) or TRE-eGFP (pT2K-BI-TREeGFP) to be 
integrated into the host genome. Activation of transcription of the TRE-driven gene (“tet-on”) occurs only in 
the presence of doxycycline. Adapted from Sato et al., 2007. 
 
 
Myoblast differentiation assay  
The myoblast differentiation assay is a classical culture assay that uses differentiation of 
C2C12 murine myoblast cell line to evaluate the activation/inhibition of Notch signaling (R 
Kopan, Nye, & Weintraub, 1994; Lindsell, Shawber, Boulter, & Gerry Weinmaster, 1995). 
Under rich-serum conditions, the murine myoblast line C2C12 remains undifferentiated with 
Notch signaling activated. If deprived of serum, C2C12 cells start to differentiate, fuse to form 
myotubes and switch-off Notch signals (Jaleco et al., 2001; Nofziger, Miyamoto, Lyons, & G 
Weinmaster, 1999). C2C12 cells will be genetically modified to express either ICN1 or 
DNMAML1. We expect that C2C12 cells expressing ICN1 (Notch1 constitutively-active) will 
maintain their undifferentiated phenotype even in conditions that normally promote 
differentiation (low-serum conditions). Conversely, C2C12 cells expressing DNMAML1 
(Notch signaling blocked) are expected to start to differentiate and form myotubes even in rich-
serum conditions.  
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I.4. Chicken model for developmental studies 
The chicken embryo has been a classic model in developmental biology since the time 
of comparative and experimental embryology, having the longest continuous history as an 
experimental model for studies in developmental biology. In the last 50 years, the chicken 
embryo has contributed to some of the most important general concepts in vertebrate 
developmental biology. The availability and low cost of fertilized eggs that can be incubated to 
specific, well characterized, stages of development; the easiness of tissue accessibility from 
pregastrulation throughout all developmental stages; the fact that chicken represents the model 
system which most resembles other higher vertebrates while still permitting experimental 
intervention in ovo, and the recent discovery that chicken share more than a half of its genes 
with human, stressing the fact that they share several biological processes, makes chicken 
embryo a powerful system for developmental biology (Bourikas & Stoeckli, 2003; Bronner-
Fraser, 2008; Stern, 2004).  
The chick-quail chimera system, developed by Le Douarin in the 1970s, have taken 
advantage of their difference in the heterochromatin structure, that could be exploited to follow 
easily the fate of grafted quail cells in chicken embryo. These chick-quail manipulations 
significantly contributed to some of developmental biology’s most important findings 
concerning induction of various tissues, fate mapping, patterning, cell lineage, and 
differentiation, because of the s. The use of chick-quail grafts was motivated by the need to 
selectively label define groups of cells in order to follow their pathways of migration and 
identify interactions during morphogenesis and organogenesis. The recent development of the 
transgenic technique by electroporation applied to the avian embryo has been an important 
advantage for this model in developmental biology. The fact that gene gain- or loss-of-function 
experiments can be combined with the chimeric technique brings about even more precision in 
the analysis of the developmental events under study, reinforcing the usefulness of the 
quail/chick model (Teillet, Ziller, & N M Le Douarin, 1999). 
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II. Objective 
The main objective of this work was to study the role of Notch signaling in early stages 
of thymic development. For that, we developed in vivo and in vitro experimental approaches of 
gain- and loss-of-function of Notch signaling in chicken. To modulate in vivo Notch signaling 
in a stable and cell-autonomous manner, two new vectors were generated expressing either the 
constitutively active form of Notch1 (ICN1) or the dominant-negative form of MAML1 
(DNMAML1). Future studies of gain- and loss-of-function of Notch signaling in thymic 
development will be performed using these two new vectors, integrated in a “Tol2-mediated 
gene transfer” and “Tetracycline-dependent conditional expression” combined system of 
vectors. Endodermal tissues of the presumptive territory of TECs will be genetically modified 
to either express ICN1 or DNMAML1; will be grafted into the body wall of a chick embryo 
and then thymic development will be followed by in situ observation.  
In vitro assays of pharyngeal region explants were performed to study the effect of 
Notch signaling inhibition during epithelial-mesenchymal interactions in early thymic 
development. 
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III. Materials and Methods 
III.1. Molecular Biology procedures 
 
Bacteria preparation and transformation 
The DH5-α strain of E. coli was used for all transformations performed in this study. 
Before these cells can be transformed they need to go through a process that allows the intake 
of exogenous DNA. Non-competent bacterial cells from frozen glycerol stock were streak out 
onto LB plates, grown and one colony was selected for a starter culture. The next day a higher 
volume of LB was inoculated with 1/100 dilution of the starter culture and incubated until it 
reached 0.3 optical density at 600 nm (OD600). The cells were kept on ice and harvested by a 
series of centrifugations in the presence of CaCl2 to generate chemically competent DH5-α 
cells; the transformation of DH5-α cells was performed by heat shock treatment for 1 min. 
Detailed protocols for both preparation and transformation of DH5-α cells are shown in the 
Appendix1. 
 
 
Plasmid DNA mini- and midi-preparation 
For mini-preparation of plasmid DNA, single colonies of transformed bacteria were 
collected and inoculated into 5 mL of liquid LB medium supplemented with ampicillin (100 
μg/mL) and incubated in a 37°C shaker (225 rpm) o.n.. The purification of plasmid DNA was 
carried out using the QIAprep® Spin Miniprep Kit (QIAGEN) according to the protocol 
recommended by the manufacturer.  
For midi-preparation of plasmid DNA, single colonies of transformed bacteria were 
grown o.n. in 50 or 100 mL (high or low copy, respectively) of liquid LB medium 
supplemented with ampicillin (100 μg/mL) at 37°C (225 rpm) o.n.. The purification of plasmid 
DNA was carried out using the QIAfilter Plasmid Midi kit (QIAGEN) according to the protocol 
recommended by the manufacturer. DNA samples were stored at -20ºC. 
 
 
Isolation of total RNA 
Total RNA extraction from chicken embryos with 3 days of development was 
performed using High Pure RNA Isolation Kit (Roche) according to the manufacturer 
specifications. Embryos were cut in pieces and resuspended in 200 µL PBS. After adding 400 
µL of Lysis/Binding Buffer and mixing 15 sec with a vortex, the samples were maintained at -
20ºC until performing to the RNA extraction protocol. The RNA pellet was eluted in 50 µL of 
Elution Buffer). RNA samples were stored at -80ºC. 
 
 
 
 
12 
 
Complementary deoxyribonucleic acid (cDNA) synthesis 
The synthesis of the first-strand cDNA from total RNA (previous section) was carried 
out using the SuperScript® III First-Strand Synthesis System for RT-PCR (Invitrogen), 
according to the manufacturer instructions. 2 μg of total RNA were used in each reaction. 
cDNAs were stored at -20ºC until needed.  
 
PCR amplification  
cDNA template synthesized from cE3 RNA (previous section) was amplified by PCR in 
a 25 µl reaction with a 0.5 µM final concentration of primers, using the Phusion™ Master Mix 
with HF Buffer (Finnzymes), according to instructions from the manufacturer. The cycling 
conditions were: 1 cycle of initial denaturation at 98ºC for 30 sec; 30 cycles of denaturation at 
98ºC for 10 sec, annealing at optimal temperature (see below) for 30 sec, and extension at 72ºC 
for 15 sec per 1Kb; and 1cycle of final extension at 72ºC for 10 min. The optimal amplification 
conditions were obtained by testing several temperature gradients and the presence or absence 
of 3% of DMSO. The use of DMSO was suggested by Phusion™ Master Mix with HF Buffer 
manufacturer for situations of high %G/C, which was the case. The optimal conditions of each 
amplification were: ICN1 - annealing temperature = 64ºC, extension= 45 sec, PCR reaction 
with 3% of DMSO (2417 bp product); DNMAML1- annealing temperature = 63.4ºC, extension 
= 15 sec (205 bp product) and MAML1- annealing temperature = 60ºC, extension = 15 sec (989 
bp product). Samples were stored at -20ºC. For the PCR reaction MyCycler™ Thermal Cycler 
(Bio-Rad) was used. 
 
Primers selection for amplification of chicken ICN1, DNMAML1 and MAML1 sequences  
 
ICN1 sequence: The start position of ICN1 sequence was identified in the valine 1792 in 
chicken, when compared to the ICN1 start position in mouse (valine 1744) (Schroeter, 
Kisslinger, & Kopan, 1998). The comparison of ICN1 amino-acid (aa) sequences between Mus 
musculus and Gallus gallus is shown below (First valine of ICN1 in bold/underlined): 
 
 Mus musculus ID: NP_032740.3 
1690 AAFLGALASLGSLNIPYKIEAVKSEPVEPPLPSQLHLMYVAAAAFVLLFFVGCGVLLSRK 1749 
         AAFLGALASLG+LNIPYKIEAVKSE    EP      SQL+   MYV      AA  VLL F+G     GVL+SRK 
1738 AAFLGALASLGNLNIPYKIEAVKSETAEPARNSQLYPMYVVVAALVLLAFIGVGVLVSRK 1797  
Gallus gallus ID: XP_415420.2 
 
In the Gallus gallus Notch1 gene, the 1792 aa corresponds to the nucleotides 5376-78. 
The end of the ICN1 sequence coincides with the end of the Notch1 sequence (the 7770 
nucleotide). Partial nucleotide sequence of Notch1 in Gallus gallus is shown below (the 
sequences chosen for primers construction are in bold, the ICN1 coding sequence is underlined 
and the stop codon that corresponds to the end of the Notch1 protein is in red): 
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Notch1 Gallus gallus Gene ID: XM_415420.2 
… 
5341 gcactggtct tgcttgcctt cattggagtg ggagtgctgg tgtcccgcaa gcggcgcagg      
5401 gagcatggcc agctctggtt cccagagggc ttcaaagtga cggagtcgag caagaagaag     
5461 cgccgggaac cacttgggga agattctgtt ggactgaaac ccctcaaaaa tgcttctgac    
(…)   
7621 gaccacccct tcctcactcc ctctccggag tctccagacc agtggtcgag ctcctcgccc      
7681 cactccaacg tgtccgactg gtccgagggc atctccagcc cccccaccag catgcagtcg      
7741 cagatgggac acatccccga ggccttcaag tgagacccag tggggctcag ggactgcagc 
… 
 
To amplify the ICN1 sequence, and allow direct cloning and further expression of ICN1 
the sequence of the 5’ primer was modified introducing a restriction site and a KOZAK 
sequence. The final primers were: forward 5’-GCTAGCCATGgtgctggtgtcccgcaag-3’ (the 
inserted sequences are in capital letter; the restriction sequence of NheI is underlined; the 
KOZAK sequence is in bold) and reverse 5’- ctgggtctcacttgaaggcctcg-3’. 
 
DNMAML1 sequence: The dominant negative form of MAML1 was first identified in mouse 
(Pear et al; Blood, 2004). This sequence (12-74 aa of MAML1) includes its exclusive binding 
domain to ICN1 and is sufficient to block Notch1-mediated transcriptional activation (Pear et 
al; Blood, 2004). Thus, we used this sequence to generate the DNMAML1 in chicken. The 
comparison of MAML1 aa sequences between Mus musculus and Gallus gallus is shown below 
(in bold the DNMAML sequence): 
Mus musculus ID: NP_780543.2 
1     MVLPTCPMAEFALPRHSAVMERLRRRIELCRRHHSTCEARYEAVSPERLELERQHTFALH  60 
       MVLP  CPMA        +PRHSAVMER      +RIELCRRHHS     CE+ RY+ AVSPERLELERQ     TFALH 
1     MVLPPCPMAHLVVPRHSAVMERPFQRIELCRRHHSACESRYQAVSPERLELERQQTFALH  60 
Gallus gallus Gene ID: XP_414607.2 
 
Mus musculus ID: NP_780543.2 
61    QRCIQAKAKRAGKHRQPPAAATAP--------VAAPAPASAPAAARLDAADGPEHGR--P  110 
        QRC+QAKAKRAGKHRQPP    A      P           VA     A    S                   +AA   G   +HGR 
61    QRCLQAKAKRAGKHRQPPPAPPPPAPPPPAAAVAGSAERSGANGLDGEAASGEQHGRSST  120 
Gallus gallus ID: XP_414607.2 
 
In the Gallus gallus MAML1 gene the 12 aa corresponds the 36-38 nucleotides and the 
74 aa corresponds to the 222-224 nucleotides. The nucleotide sequence of MAML1 Gallus 
gallus is shown below (the sequences chosen for primers are in bold, the DNMAML1 sequence 
is underlined): 
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MAML1 Gallus gallus ID: XM_414607.2  
 
1 atggtgctgc ccccctgccc catggcccat ttagtggtgc cgcggcacag cgcggtgatg 
61 gagcggccct ttcagcgcat cgagctctgc cggcggcacc acagcgcctg cgagtcccgc 
121 taccaggccg tgtccccgga gcgcctggag ctggagcgcc agcaaacctt cgccctgcac 
181 cagcgctgcc tgcaggccaa ggccaagcgg gccggcaagc accgccagcc gcccccggcc 
… 
 
To amplify the DNMAML1 sequence, and allow direct cloning and further expression 
of DNMAML1 the sequence of the 5’ primer was modified introducing a restriction site and a 
KOZAK sequence. The final primers were: forward 5’- GCTAGCCATGgtggtgccgcggcacagc-
3’ (the inserted sequences are in capital letter; the restriction sequence of NheI is underlined; 
the KOZAK sequence is in bold) and reverse 5’- TCATCAgtgcttgccggcccgcttgg-3’ (the 
inserted sequence of two stop codons is in capital letter). 
 
MAML1 sequence: To generate a 989 bp riboprobe for chicken MAML1 gene (GenBank 
database sequence ID: XM_414607.2), the following primers were used: forward 5’-
cctgtgaggacaagcagtca- 3’ and reverse 5’-aacaggtgcaaaggaaatgg-3’. The product amplified 
corresponds to the sequence of the gene containing nucleotides 907-1895. 
 
 
Restrictions Digestions 
Enzymatic restriction of DNA was performed for approximately 2 h using 
commercially available restriction enzymes and respective buffers (Promega, New England 
Biolabs). The volume of reaction depended on the quantity of DNA (as a rule final volume 
should be 10x higher (in µL) than the quantity of DNA (in µg)). The volume of enzyme used in 
each reaction never exceeded 10% of the total reaction volume. In all cases the temperature of 
reaction was 37ºC. 
 
 
TOPO II PCR cloning 
PCR products were cloned in TOPO II PCR vector using Zero Blunt® TOPO® PCR 
Cloning Kit (Invitrogen) according to manufacturer instructions. Afterwards, the mix was used 
to transform competent DH5α bacteria. Then 250 μL of S.O.C. medium (TOPO® PCR Cloning 
Kit) was added and transformed cells were incubated in a 37°C shaker for 45 min (200 rpm). 
Bacteria were plated (20 μL and 100 μL) on solid LB agar medium supplemented with 
ampicillin (50µg/mL) (Sigma) and 30 μL of X-Gal (50mg/mL) (Promega) and were incubated. 
at 37ºC o.n.. Plasmid DNA was extracted as described (section Plasmid DNA Mini Preparation 
and Midi Preparation). Restriction analysis and DNA sequencing was performed to confirm the 
correct construction and correct sequence of the insert (PCR amplification product).  
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Cloning of ICN1 and DNMAML1 into the pT2K-BI-TREeGFP to generate pT2K-
ICN1eGFP and pT2K-DNMAML1eGFP 
A second cloning reaction was performed to create the final recombinant plasmids. 
TOPO-ICN1, TOPO-DNMAML1 and pT2K-BI-TREeGFP were digested with EcoRV and 
NheI restriction enzimes. 3 μg of TOPO-ICN1 and 8 μg of TOPO-DNMAML1 were digested, 
each in a total reaction volume of 80 μL. For pT2K-BI-TREeGFP vector, 2 μg of DNA was 
digested in a total reaction volume of 30 μL. Afterwards, reaction products were loaded on an 
agarose gel (see section Agarose gel electrophoresis) and DNA fragments of interest were 
recovered and purified (see section Qiaquick gel extraction kit). 
The ligation reaction of the linearized vector and insert (with the correct termini) was 
performed according to the formula: μg of vector/vector’s dimension = 10x (μg of 
insert/insert’s dimension). For the ligation reactions we used 50 ng of pT2K-BI-TREeGFP 
(8.7kb). For the ICN1 construct we used 150 ng of the insert (ICN1 insert with 2417bp) in a 
total volume of 20 μL and for the DNMAML1 construct we used 12.5 ng of the insert 
(DNMAML1 insert with 205bp) in a total volume of 15 μL. The reactions were made in 1X 
Buffer for T4 DNA Ligase (Biolabs), with 1-2 μL T4 DNA ligase (Biolabs 400U/μL) at room 
temperature (22ºC) o.n.. The reaction product was directly used to transform DH5-α competent 
cells. Plasmid DNA was extracted and isolated. The correct orientation of the inserts (ICN1 and 
DNMAML1) into the vector (pT2K-BI-TREeGFP) was confirmed using single and double 
digestion with EcoRV and KpnI. Sequencing analysis was performed to verify the insert 
sequences.  
 
 
Qiaquick gel extraction kit 
DNA extraction from agarose gel was carried out using the QIAquick Gel Extraction 
Kit (QIAGEN), according to manufacturer instructions. DNA was eluted with 50 μL of sterile 
distilled water.  
 
 
 DNA and RNA quantification 
The concentration of nuclear acids was determined by spectrophotometry using the 
NanoDrop® ND-1000 Spectrophotometer (Thermo Scientific). One A260 unit corresponds to 50 
μg/ml of double-stranded DNA and to 40 μg/ml of single-stranded RNA. Samples purity was 
evaluated based on A260/A280 ratio (pure preparations of DNA and RNA, i.e., without 
significant amounts of proteins or phenol contaminants, show ratio values of 1.8 and 20, 
respectively). 
 
 
Preparation of riboprobes for in situ hybridization 
To generate the antisense and sense transcripts, TOPO II PCR plasmids containing the 
sequence of interest, were linearized with the appropriate restriction enzyme (see appendix I).  
The digestion reaction was performed in a total volume of 150 μL containing 20 μg of DNA, 15 
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μL of 10X enzyme buffer, 5 μL of restriction enzyme (6 U-20 U/μL) and RNase-free water. 
After digestion, linearized plasmid DNA was purified using phenol:chloroform extraction and 
ethanol precipitation (see appendix II). The synthesis of digoxigenin (DIG) -labelled antisense 
and sense RNA probes was carried out by in vitro transcription at 37°C for 2h. The reaction 
contained 8 μL of Transcription Optimized 5X Buffer (Promega), 4 μL of 0.1M DTT 
(Promega), 2 μL of each rGTP, rATP, rCTP (10 mM) (Roche), 1,3 μL of rUTP (10 mM) 
(Roche), 0,7 μL of Digoxigenin-11-UTP (10 mM) (Roche), 2 μL of RNasin® Ribonuclease 
Inhibitor (Promega) and 8 μL of RNAse free water. To this mixture solution and 2 μL of the 
appropriate RNA polymerase (see appendix I), 2 μL (2g) of the linearized templates were 
added. After incubation for riboprobe synthesis, the sample was treated with 6 μL of DNase I 
recombinant RNase-free (10 U/μL) (Roche) at 37°C for 15 min. Purification of the probe was 
performed using illustra MicroSpin G-50 Columns (GE Healthcare) according to manufacturer 
instructions. To check for probe quality and success of transcription reaction, 2 μL of reaction 
product were analyzed by agarose gel electrophoresis (see below).The samples were stored at -
80ºC. 
 
 
Agarose gel electrophoresis 
Agarose gel electrophoresis was used to confirm PCR amplification products and the 
complete digestions with restriction enzymes, to recover and purify specific DNA fragments 
using extraction kit and to check riboprobe and DNA samples integrity. UltraPureTM Agarose 
(Invitrogen) was dissolved by heating in 1X TAE buffer (composition provided in Appendix I) 
to a final concentration of 0.8-1.5% (according to the required resolution for DNA fragment). 
To check for the presence of nuclear acids, GelRedTM Nucleic Acid Gel Stain (Biotium) or 
SYBR® Safe DNA Gel Stain (Invitrogen) were added to this solution in a 1:10 proportion. 
Samples were mixed with 6X MassRuler™ DNA Loading Dye (Fermentas) in 6:1 proportion 
and were loaded into the gel. Electrophoresis was performed in 1X TAE at 5-10 V/cm of gel 
lenght. Samples were observed under UV light and images acquired with AlphaImager HP 
(Alpha Innotech). The size of the fragments was estimated by comparison with the DNA 
ladders (FastRuler™ Low Range DNA Ladder, FastRuler™ Middle Range DNA Ladder or 
O'GeneRuler™ 1 kb DNA Ladder, Fermentas) run along with DNA samples. 
 
 
III.2. Cellular Biology procedures 
 
Maintenance of C2C12 murine cell line 
The murine C2C12 cell line (provided by Christel Brou from Alain Israel’s group, 
Unité de Biologie Moléculaire de l’Expression Génique, Institut Pasteur, Paris, France) was 
maintained undifferentiated in medium containing DMEM (Invitrogen) supplemented  with 
20% of FBS (Invitrogen) and 1x Pen/Strep (Invitrogen). The cells were cultured on T25, T75 or 
T175 flasks (Nunc) using a media volume to surface area ratio of 0.1-0.2 mL/cm2. All cultures 
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were grown in a humidified incubator (Heraeus® HERAcell®) at 37ºC with 5% of CO2. 
C2C12 cell line aliquotes were taken from the liquid azote and put in a 37ºC bath, without 
immerging, long enough to start to thaw. Immediately after, the cells were resuspended in 
maintenance medium and plated onto a T75 flask. The medium was changed regularly until 
cells reached 20% confluence (higher cell confluence induces differentiation). For this, the 
media was removed and the cells were washed with PBS. In order to detach the cells, pre-
warmed 1-2 mL of 0.25% Trypsin/EDTA (Sigma) was added and the cells were incubated at 
37ºC for about 5 min. When cells detached, trypsin was inactivated by addition of medium. For 
dilutions the appropriate volume was taken and plated.  
 
Differentiation assay 
C2C12 cell differentiation was induced with DMEM medium (Invitrogen) containing 
2% of Horse Serum (Invitrogen) and 1x Pen/Strep (Invitrogen). Cells from two T175 flasks 
with 10% confluence of C2C12 were trypsinized, recovered by centrifugation at 1200 rpm for 5 
min using Sorvall RT7 Plus RTH-750. Cells from each flask were resuspended in 4 mL of 
medium (cells from one flask resuspended in maintenance medium and cells from the other 
flask in differentiation medium).  For each medium condition, 2 mL of cell suspension was 
plated in one well of a 6-well, flat-bottomed plate (TPP) covered with10x10 mm cover slips 
pretreated with 0.1% gelatin (m/v) in water (Sigma).  After 24h, Troponin T expression was 
assessed by immunocytochemistry in cultured cells (see next section).  
 
Immunocytochemistry for Troponin-t 
To perform the immunocytochemistry for Troponin-T, C2C12 cells were fixed in 3.7% 
PFA/PBS, o.n.. Cells were then permeabilized with 0.5% TritonX-100 (Sigma) in PBS for 15 
min, and washed 3 times with PBT (composition in appendix I) for 5 min. Then, the primary 
antibody (Monoclonal Mouse anti Troponin-t, CT3 - Developmental Studies Hybridoma Bank, 
1:10 in PBS) was added and incubated in a humidity chamber at 37ºC for 30 min. Three washes 
of 5 min with PBT were followed by the addition and incubation of the secondary antibody 
(Policlonal Goat Anti-Mouse IgG + IgM (Jackson Immunoresearch Labs)) in a humidity 
chamber at 37ºC for 30 min. Three final washes of 5 min with PBT were performed and the 
cover slips were plated upside-down in slides with 15µL of VECTASHIELD® Mounting 
Medium (VectorLabs) (containing DAPI). The cover slips were sealed with nail polish and 
stored protected from light. The immunofluorescence data was acquired with Leica DM5000B 
Widefield Fluorescence Microscope.  
 
Electroporation of C2C12 
C2C12 cells were electroporated with the pT2K-CAGGS-EGFP and pCAGGS-T2TP 
vectors (Sato et al., 2007) to assess the best electroporation conditions and efficiency rate of the 
procedure. Electroporation of C2C12 was performed using Gene Pulser® II Electroporation 
System device (Bio-Rad). To assess the best electroporation conditions, several conditions from 
1 to 3 pulses of 500 V to 1650 V were tried. Cells were harvested from the flasks by 
trypsinization and centrifugation (procedures mentioned above), and resuspended in a proper 
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volume of PBS (800 µL/2 mm electroporation cuvette). Cell numbers from 1x105 to 1x106 and 
20 µg of each vector were added slowly through the wall of each cuvettes avoiding bubble 
formation. The cuvette walls were dried and placed in contact with the electrodes. After, the 
pulsed cells were plated in T75 flasks with maintenance medium. The next day the medium 
was replaced to remove dead cells and a preliminary quantification of GFP positive C2C12 
cells was obtained by eye observation using Leica DMIL inverted microscope. At all times a 
negative control was employed, using the same conditions without DNA. The percentage of 
GFP positive C2C12 cells was obtained by Flow Cytometry. To do so, ≥1x104 cells were added 
to a cytometry tube and the fluorescence data was acquired in the FACSCalibur flow cytometer 
(Becton Dickinson). 
 
Transfection of C2C12 
C2C12 cells were transfected with the pT2K-CAGGS-EGFP and pCAGGS-T2TP 
vectors (Sato et al., 2007) using FuGENE 6 Transfection Reagent (Roche) according to 
manufacturer instructions. C2C12 cells grown until 20% confluence were trypsinized and 
1x105 cells were suspended in a 2 mL of maintenance medium and plated in a 6-well, flat-
bottomed plate (TPP). After 24 h of culture and 3 h prior to transfection, the media was 
changed to 1 mL of DMEM (medium without serum and antibiotics). Three concentrations of 
FuGENE reagent (3, 6 and 9 µL) were tested, as well as two DNA concentrations (1 and 2 µg 
of pT2K-CAGGS-EGFP and pCAGGS-T2TP each). After further 16h, the supernatant of the 
transfection mix (DMEM with DNA and FuGENE) was removed and the cells from each well 
were trypsinized, resuspended in maintenance medium and plated into T75 flasks (Nunc). After 
a few days in culture (with replating to maintain cell confluence ≤20%) GFP positive cells were 
quantified by Flow Cytometry, using the same method as mentioned in the previous section. 
 
 
III.3. Developmental Biology procedures 
Chicken embryo manipulation 
Fertilized chicken eggs were obtained from Sociedade Agrícola Quinta da Freiria, S.A., 
Portugal, stored at 16ºC and incubated at 38ºC to initiate development. Embryos were staged 
according to Hamburger and Hamilton (Hamburger & Hamilton, 1951). At specific stages of 
development, embryos were dissected from the eggs, and the extra-embryonic membranes 
removed. Embryos were further processed differently depending on the method used 
subsequently: isolation of RNA, whole mount in situ hybridization or in vitro culture of 
branchial arch explants. 
 
In ovo electroporation of neural tube 
The neural tube of E2 chicken embryos was first injected with different combination of 
vectors (Fig. 5A), then electroporated and finally administrated with doxycycline to induce 
GFP and Notch construct expression in the vector system (Fig. 5B). Control conditions were 
performed by electroporating embryos with a mix of the four vectors: pT2K-CAGGS-
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rtTA2SM2, pT2K-BI-TREeGFP, pCAGGS-T2TP (Sato et al., 2007) and pCAG-CherryNLS 
plasmid (encoding a nuclear form of a red fluorescent protein driven by the constitutive CAG 
promoter (Vilas-Boas, Fior, Swedlow, Storey, & Domingos Henrique, 2011). Plasmid pT2K-
BI-TREeGFP and pCAGGS-T2TP were at around 2 µg/µL; however pT2K-CAGGS-
rtTA2SM2 and pT2K-BI-TREeGFP were at 1:2 proportion as recommended by Watanabe and 
collaborators (Watanabe et al., 2007). The same proportions were used for all plasmids when 
injecting recombinant plasmids pT2K-ICN1eGFP and pT2K-DNMAML1eGFP (instead of 
pT2K-BI-TREeGFP). pCAG-CherryNLS plasmid was at a concentration of 0,1 µg/µL and was 
used as a control vector to assess the electroporation efficiency. Fast Green was used in the 
plasmid mix a 1:10 proportion to dye the DNA mix to visualize of the injection site and to 
follow the distribution of the injected solution in the embryo. 
 
 
 
DNA solution was injected into the lumen of the neural tube of E2 chicken embryos 
with a microinjection capillary glass (Harvard Apparatus), using the Inject + Matic 
Microinjector (Inject + Matic) (Fig. 5A). Platinum electrodes (Nepagene), distanced 4 mm 
apart were placed parallel to the neural tube on the surface of the embryo, along the 
anteroposterior axis (Fig. 5A), and some drops of PBS with 1x Pen/Strep were added to the 
surface of the embryo. Using an ElectroSquare Porator ECM830 (BTX), 4 pulses of 25 V for 
50 ms, spaced by 100 ms were applied twice. The side of the neural tube closer to the positive 
electrode was the experimental side (having directional entry of DNA into those cells), while 
the other was the control side (Fig. 5B). Immediately after electroporation, 500 µL of 
0.1mg/mL doxycycline hyclate (doxycycline Sigma) in Hank’s Buffered Salt Solution (HBSS, 
Invitrogen) (Sato et al., 2007) were injected between the embryo and the yolk, using a 1 mL 
syringe and without penetrating the area opaca (Watanabe et al., 2007). For each experimental 
condition, embryos were electroporated with either the ICN1 or DNMAML1 DNA mix of 
Figure 5. In ovo electroporation of the neural 
tube of chick embryos.  A) Schematic 
representation of an HH13 embryo (E2) (adapted 
from Hamburguer & Hamilton,1951) injected with 
DNA solution into the neural tube’s lumen 
previous to electroporation. Electrodes position 
and polarity are shown by bars and by minus (-) 
and plus (+) signs, respectively. B) Schematic 
representation of the electroporation of a neural 
tube injected with DNA solution (blue) followed 
by DOX administration to induce gene expression. 
GFP (green) and CherryNLS (red) expression are 
expected in the right side of the neural tube, 
according to electrodes position; n:neural tube, 
n:notochord. 
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recombinant plasmids. In parallel, a set of embryos were electroporated with the control mix of 
DNA vectors.  
Embryo viability, CherryNLS and GFP expression were evaluated over time, at 16-24 
h, 42-48 h and 66-72 h after electroporation, using Leica MZ10F Fluorescence 
stereomicroscope equipped with an Evolution™ MP 5.0 Mega-pixel Camera Kit (Media 
Cybernetics). Electroporated embryos were harvested and fixed in 3.7% PFA/PBS at 4ºC o.n. 
and further in situ hybridized with Hes5-1.  
 
In vitro culture of pharyngeal region explants 
The region between the first and the fourth branchial arches was dissected from E3.5 or 
E4 embryos (Fig. 6A and B) on PBS, the dorsal zone was cut open vertically along the 
anteroposterior axis (along the notochord) and kept on ice until culture. Some dissected 
pharyngeal region explants (E4) were directly fixed to further analyze the expression patterns at 
day zero (d0) of culture by in situ hybridization.  The explants were placed with the opened 
dorsal side down and in contact with the culture medium. Explants were grown on 24 mm 
Netwell™ Insert with 74 µm Mesh Size Polyester Membrane (Corning), for 48 h (E4 explants) 
or 60 h (E3.5 explants) in a humidified incubator at 37ºC with 5% CO2 (Fig. 6B). 
In control culture condition, explants were grown in RPMI-1640 Medium (Sigma) 
supplemented with 10% FBS (Invitrogen), 1x Pen/Strep (Invitrogen) and DMSO (Sigma). For 
Notch signaling inhibition, medium from control condition was supplemented with either 25 
µM or 50 µM of DAPT – InSolution™ γ-Secretase Inhibitor IX (Calbiochem). After 48 h or 60 
h of culture, explants were equilibrated in PBS and fixed in 3.7% PFA/PBS at 4ºC, o.n.. In the 
following day, fixed explants were hybridized with antisense riboprobes for Foxn1, Gcm2, 
Hes5-1 or Hes6-1 genes, as described in next section. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Schematic representation of the in vitro culture assay. A) Dissection of the pharyngeal region of 
chicken embryo. B) Ventral view of the dissected explant with Pharyngeal Arches (PA) and Pharyngeal 
Pouches (PP) identified. C) Explant placed in culture in the presence or absence of Notch signaling inhibitor- 
DAPT. (A, anterior; L, left; P, Posterior; R, Right).  
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Whole-mount and explant tissues in situ hybridization 
In situ hybridization of whole-mount and pharyngeal region explants of chicken 
embryos were performed as previously described (Henrique, 1995 and Etchevers, 2001) 
(detailed protocol in the appendix II). Whole-mount preparations and pharyngeal region 
explants were hybridized with several riboprobes: antisense and sense for ICN1, DNMAML1 
and MAML1; antisense for Foxn1 (Hélia Neves et al., 2011 in press), Gcm2 (Hélia Neves et al., 
2011 in press), Hes5-1 (Vilas-Boas et al., 2011) and Hes6-1 (Vilas-Boas & Domingos 
Henrique, 2010). Pictures were taken under a Leica Z6 APO equipped with a Leica DFC490 
camera. 
 
 
IV. Results 
IV.1. In vivo modulation of Notch signaling in the 3/4PP endoderm 
To modulate Notch signaling in the prospective thymic epithelium compartment we 
aimed to genetically modify 3/4PP endoderm using a combined system of transposon-mediated 
transgene and tetracycline-induced conditional expression (Sato et al., 2007; Watanabe et al., 
2007). We started to generate two recombinant plasmids, having the intracellular domain of 
Notch1 (ICN1) or a dominant negative form of MAML1 (DNMAML1) into the pT2K-BI-
TREeGFP vector, to constitutively activate or block Notch signaling, respectively.  To clone 
the ICN1 and DNMAML1 sequences into pT2K-BI-TREeGFP, three steps were performed: 
PCR reaction to amplify the sequences of interest; cloning of the amplified sequences into 
TOPO II PCR Vector and then subcloning them into pT2K-BI-TREeGFP.  
 
 
IV.1.1. Production 
 
To produce pT2K-ICN1eGFP vector, a 2417 bp cDNA product derived from PCR 
amplification of ICN1 (Fig. 7A, ICN1 lane) was cloned into TOPO II PCR (4 kb). As expected, 
the digestion of TOPO-ICN1 with EcoRV and NheI showed two DNA bands: one of 4 kb 
(TOPO II PCR) and another with 2417 bp (ICN1 insert) (Fig. 7A, TOPO-ICN1 lane). The 
second step consisted of subcloning the EcoRV/NheI ICN1 purified insert, from TOPO-ICN1, 
in the pT2K-BI-TREeGFP (8.7 kb) digested with EcoRV/NheI. Integrity of pT2K-BI-
TREeGFP, was confirmed by the observation of an 8.7 kb DNA band when linearized with 
EcoRV (Fig. 7A, pT2K-BI-TREeGFP lane). The final construct obtained, the pT2K-
ICN1eGFP, when digested with EcoRV and NheI showed two DNA bands: one of 8.7 kb 
(vector) and another with 2417 bp (ICN1 insert) (Fig. 7A, pT2K-ICN1eGFP lane). 
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Figure 7. Agarose gels showing the several steps involved on the generation of Notch constructs. A) 
0.8% (wt/vol) agarose gel showing the steps involved in the construction of pT2K-ICN1eGFP and B) 1.6% 
(wt/vol) agarose gel showing the steps involved in the construction pT2k-DNMAML1eGFP. Fragment sizes 
were determined by comparison with O'GeneRuler™ 1 kb DNA Ladder (L1) and FastRuler™ Middle Range 
DNA Ladder (L2). The corresponding band sizes and procedures are distinguished in the tables; DNA 
molecular weight markers are indicated (bp). The arrowhead in A) indicates star activity of EcoRV. 
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To produce the pT2K-DNMAML1eGFP vector, a 205 bp cDNA product derived from 
PCR amplification of DNMAML1 (Fig. 7B, DNMAML1 lane) was cloned into TOPO II PCR. 
When the plasmid TOPO-DNMAML1 was digested with EcoRV and NheI two DNA bands of 
4 kb (vector) and 205 bp (DNMAML1 insert) were observed (Fig. 7B, TOPO-DNMAML1) as 
expected. Nextthe EcoRV/NheI DNMAML1 purified insert, obtained from TOPO-
DNMAML1, was subcloned in the pT2K-BI-TREeGFP digested with EcoRV/NheI. Integrity of 
pT2K-BI-TREeGFP, was confirmed by the observation of an 8.7 kb DNA band when 
linearized with EcoRV (Fig. 7B, pT2K-BI-TREeGFP lane). The final construct obtained, the 
pT2K-DNMAML1eGFP, was confirmed by digestion with EcoRV and NheI: two DNA bands 
of 8.7 kb (vector) and 205 bp (DNMAML1 insert) were observed (Fig. 7B, pT2K-
DNMAML1eGFP lane).  
To confirm the correct sequence and orientation of ICN1 and DNMAML1 inserts into 
the pT2K-BI-TREeGFP, the final vectors, pT2K-ICN1eGFP and pT2K-DNMAML1eGFP were 
analysed by DNA sequencing at the insert region (full result in appendix III). 
 
 
IV.1.2. Functional analysis 
 
IV.1.2. a) Myoblast differentiation assay 
 
To evaluate the reliability of Notch constructs in this system (previous section) to 
modulate Notch signaling we used the functional C2C12 myoblast differentiation assay (R 
Kopan et al., 1994; Lindsell et al., 1995). We aimed to express in myoblast cells either a 
constitutively active form of Notch1 (ICN1) or a dominant negative form of MAML1 
(DNMAML1) to promote the gain or loss-of-function of Notch signaling, respectively. It is 
known that when Notch signaling is activated, the C2C12 cells remain undifferentiated (even in 
differentiation medium) (Jaleco et al., 2001; Nofziger et al., 1999). In contrast, a down 
regulation of Notch signaling occurs when C2C12 cells start to differentiate into muscle.  
As previously described, we observed that C2C12 cell line grows as single cells and 
does not express troponin-t (Fig. 8AII) in maintenance medium. In differentiation medium, 
C2C12 cells start to fuse (white arrow head in Fig. 8AV) and to express troponin-t (Fig. 8AIV) 
(Jaleco et al., 2001). 
 
To stable integrate the Notch constructs into C2C12 cells we used two methods, 
electroporation and transfection with FuGENE reagent. To assess electroporation conditions 
and the efficiency of the procedure, we started to electroporate undifferentiated C2C12 cells 
with pT2K-CAGGS-EGFP and pCAGGS-T2TP. The highest percentage of GFP positive cells 
obtained (3.13%) with the electroporation method was using 1 pulse of 800 V (Fig. 8BII). The 
remaining conditions tested (see material and methods) always presented lower percentage of 
GFP positive cells. In parallel, C2C12 cells were transfected with pT2K-CAGGS-EGFP and 
pCAGGS-T2TP using FuGENE reagent. The highest percentage of GFP positive cells (3.75%) 
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was obtained with 6 µL of FuGENE and 1 µg of total DNA for both plasmids (Fig. 8BIV). The 
remaining conditions tested (see material and methods) always presented lower percentage of 
GFP positive cells. In the control conditions, C2C12 cells electroporated or transfected without 
DNA, any GFP positive cells were observed (Fig. 8BI and III, respectively). Together, our 
results showed a low efficiency in the electroporation and transfection of C2C12 cells. Thus, 
the functional evaluation of Notch constructs in the modulation of Notch signaling required a 
different experimental approach. 
 
 
 
 
 
 
 
 
 
Figure 8. C2C12 Differentiation Assay and Analysis of GFP expression on transfected C2C12 cells. A) 
Immunocytochemistry of C2C12 for Troponin-t and DAPI in maintenance and in differentiation medium.  
(C2C12, proliferating C2C12 cells; DM, differentiation medium.) Scale bars: 50 µm. B) Flow cytometry 
analysis of GFP expression on transfected C2C12 cells with pT2K-CAGGS-EGFP and pCAGGS-T2TP by 
Electroporation (II) or Transfection with FuGENE reagent (IV), and corresponding controls (without DNA) (I 
and III).  
 
IV.1.2. b) In ovo electroporation 
  
A distinct experimental approach using in ovo electroporation was further used to test 
the functionality of the recently generated Notch constructs. It is known that in the developing 
nervous system, Hes5-1 is a direct target of Notch signaling (De La Pompa et al., 1997; Lütolf 
et al., 2002; Nishimura et al., 1998), when Notch signaling is blocked a downregulation of this 
target gene is observed (Vilas-Boas et al., 2011).  
Neural tubes of E2 embryos were electroporated with tree different plasmids 
combinations to assess the expression of either a constitutively active form of Notch1 (ICN1) 
or a dominant-negative form of MAML1 (DNMAML1). Embryos were coelectroporated with 
three combinations of vectors: pT2K-CAGGS-rtTA2SM2, pT2K-BI-TREeGFP and pCAGGS-
T2TP plasmids (control condition); pT2K-CAGGS-rtTA2SM2, pT2K-ICN1eGFP and 
pCAGGS-T2TP plasmids (ICN1 condition); pT2K-CAGGS-rtTA2SM2, pT2K-DN1eGFP and 
pCAGGS-T2TP plasmids (DNMAML1 condition).  
A 
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We started by assessing the electroporation outcomes: the viability of the electroporated 
embryos, the efficiency of electroporation (CherryNLS expression) and the efficiency of the 
system of vectors (GFP expression) at three distinct time points (at 16-24 h, 42-48 h and 66-72 
h of development post-electroporation). 
The viability of electroporated embryos decreased over time and varied between DNA 
conditions (Table 3, viability column). For control condition, 81%, 40% and 38% of 
electroporated embryos were alive at 16-24 h, 40-48 h and 64-72 h, respectively (Table 1). 
Similarly, 82%, 74% and 9% of electroporated embryos with DNMAML1 condition were alive 
at the same time points (Table 1). Only 17% (N=2/12) of ICN1 electroporated embryos were 
alive at 40-48 h (Table 1), the only time point evaluated for this condition.  
 
 
Table 1. Time course analysis of Viability and CherryNLS expression in the all experimental conditions 
(Control, DNMAML1 and ICN1) of the in vivo neural tube electroporation at the three distinct time 
points studied. 
 
 
 
 
 
All time points indicate the hours post-electroporation. (N.D., Not Done). 
 
 
Table 2. Time course analysis of GFP positive embryos in the all experimental conditions (Control, 
DNMAML1 and ICN1) of the in vivo neural tube electroporation at the three distinct time points 
studied.  
 
 
 
 
 
 
 
All time points indicate the hours post-electroporation. (N.D., Not Done). * Isolated embryos for further 
 manipulation for in situ hybridization with Hes5-1.
 
In control condition, the efficiency of electroporation (obtained at 16-24 h post-
electroporation) was 100% (Table 1, CherryNLS expression column). Although expression was 
maintained over time in control embryos, a decrease in its intensity was observed (Fig. 9AII, VI 
and X). In contrast, the efficiency of electroporation in DNMAML1 condition was 77% and the 
percentage of embryos expressing CherryNLS increased over time (77%, 96% and 100%), as a 
result of death of electroporated embryos (Table 1). In the single experiment of electroporation 
with the ICN1 construct, only one of the 2 viable embryos showed CherryNLS expression at 
40-48 h (Table 1).  
 
26 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. In ovo electroporation of the neural tube of chick embryos.  A) In vivo time course analysis of 
CherryNLS and GFP expression in embryos co-electroporated with pT2K-CAGGS-rtTA2
S
M2, pT2K-BI-
TREeGFP, pCAGGS-T2TP and pCAG-CherryNLS (Control). Embryo stages adapted from Hamburguer & 
Hamilton, 1951. B) Expression of Hes5.1 detected by whole-mount in situ hybridization in the neural tube of 
electroporated chicken embryos. Hes5.1 expression in the neural tube of embryos at 64-72 h after co-
electroporation with the control combination of plasmids (I, II) or with the DNMAML1 combination of 
plasmids (III, IV). Hes5.1 expression in the neural tube of embryos at 40-48 h after co-electroporation with 
the control combination of plasmids (V, VI) or the ICN1 combination of plasmids (VII, VIII). Electroporated 
side (arrow head) and non-electroporated side (asterisk). Scale bars: 500 µm.  
 
To assess the efficiency of this vectors system the percentage of GFP positive embryos 
was calculated in relation to CherryNLS expressing embryos, at the three distinct time points 
(Table 2). In control condition, the percentage of GFP positive embryos was 9.6% at 16-24 h, 
and increased 4.5 folds (42.8%) after further 24 h of development (Fig. 9AIII and VII; Table 2). 
* * 
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This effect was due to the GFP expression in new and different embryos at 40-48 h and to some 
death of CherryNLS expressing embryos. At 64-72 h, the remaining control embryos continued 
to show GFP expression (Fig. 9AXI; Table 2). In the DNMAML1 condition, 2/22 (9%) 
CherryNLS expressing embryos showed GFP expression (data not shown) only at 40-48 h 
(Table 2).  In ICN1 condition, no GFP expression was observed in CherryNLS expressing 
embryos at 40-48 h post-electroporation, the only time point analyzed (Table 2).  
Electroporated embryos from the three experimental conditions were isolated and in 
situ hybridized with antisense riboprobe for the Hes5-1 gene. In DNMAML1 condition, four 
CherryNLS expressing embryos were isolated, two embryos at 40-48 h showing weak GFP 
expression and two at 64-72 h with no GFP expression. Embryos isolated at 40-48 h showed 
normal Hes5-1 expression in the neural tube (data not shown), similar to control embryos 
(N=7/7, Fig. 9BI and II). Surprisingly, embryos isolated at 64-72 h showed an absence of Hes5-
1 expression in the left side of the neural tube (electroporated side, arrow head in Fig. 9BIII and 
IV), when compared to the right side (non-electroporated side, asterisk in Fig. 9BIII and IV). As 
expected, control embryos isolated and hybridized at the same time point showed similar levels 
of Hes5-1 expression in both sides of the neural tube (Fig. 9BI, II, V and VI). The GFP negative 
embryo obtained from ICN1 condition at 40-48 h also showed similar levels of Hes5-1 
expression in both sides of the neural tube (Fig. 9BVII and VIII).   
These data showed that cells of the neural tube when expressing DNMAML1 abolish 
the expression of the Notch target gene, Hes5-1. Further assays are required to evaluate the 
capacity of ICN1 to upregulate the expression of Hes5-1 in electroporated cells of the neural 
tube. 
 
IV.2. Expression of Notch signaling related genes in chicken embryos at stages 
of development prior to thymic epithelium specification 
IV.2.1. Expression of Notch1 and MAML1 in chick embryos at E3 and E4 
 
IV.2.1.1. Notch1 
 
A new riboprobe for the intracellular domain of Notch1 gene was developed from the 
TOPO-ICN1. Antisense and sense (for control of probe quality) ICN1 riboprobes were 
synthesized and in situ hybridized into E3 and E4 chicken embryos. As expected, the pattern of 
Notch1 expression using the antisense ICN1 probe was similar to those observed when using 
probes for other regions of Notch1 gene (at http://geisha.arizona.edu/geisha/index.jsp). The 
pattern of Notch1 expression was similar in the two stages of development studied. We 
observed strong expression of Notch1 in the neural tube, cephalic vesicles (fore, mid and hind-
brain) and otic vesicle (E3 in Fig. 10A-D and E4 in Fig. 10F-I). Furthermore, expression was 
observed in the optic vesicle (lens domain at E3, asterisk in Fig. 10B; boundaries of optic cup, 
asterisk in Fig. 10G), in the pharyngeal arches and ventral aorta (asterisks in Fig. 10C and H), 
in the boundaries of somites and in the distal portion of the limb (asterisks in Fig. 10D and I). 
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No detectable hybridization signals were observed in E3 and E4 embryos hybridized with ICN1 
sense probe (Fig. 10 E and J).  
 
 
 
Figure 10. Expression of Notch1 and MAML1 in chicken embryos prior to thymic epithelial cells 
specification (at E3 and E4).  Notch1 expression (A, B, C, D, F, G, H, I) detected by whole-mount in situ 
hybridization with the ICN1 antisense riboprobe: in the head (B), in the pharyngeal region (C) and in the limb 
(D) at E3 (A to D) and E4 (F to I). In situ hybridization with ICN1 sense riboprobe at E3 (E) and E4 (J). 
MAML1 expression (K, L, M, N) was analyzed by whole-mount in situ hybridization with MAML1 antisense 
riboprobe: in the head (K), in the pharyngeal region (M) and in the limb (N) at E4. In situ hybridization with 
the MAML1 sense riboprobe at E4 (O). Asterisks indicate the optic vesicle (B, G and L), the ventral aorta (C 
and H), the limb (D, I and N) or the hind-brain (O); black arrow heads indicate the 3
rd
 and 4
th
 pharyngeal 
pouches; white arrow head indicate the otic vesicle. (O.V., Otic Vesicle; PA, Pharyngeal Arches; PP, 
Pharyngeal Pouches) Scale bars: 500 µm. 
 
IV.2.1.2. MAML1 
 
We first design a new riboprobe for the truncated form of MAML1 gene (205 bp, 
DNMAML1) from TOPO-DNMAML1. The antisense and sense DNMAML1 riboprobes were 
synthesized and in situ hybridized into E3 and E4 chicken embryos. Faint hybridization signals 
were observed in the pharyngeal arches and cephalic vesicles (data not shown).  
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In order to improve our riboprobe to a more specific one, we produced a riboprobe with 
a longer sequence of the gene (989 pb) and hybridized it into E4 embryos. We observed strong 
hybridization signals in similar regions to those previously reported when using DNMAML1 
antisense probe. Specifically, strong expression of MAML1 was observed in the fore, mid and 
hind-brain, the lens of the optic vesicle (Fig. 10L; asterisk indicate the lens of the optic vesicle) 
and in the dorsal portion of the otic vesicle (asterisk in Fig. 10M). In the pharyngeal region, 
MAML1 expression was found in a narrow region between the 1st and 2nd PA (with arrowhead 
in Fig. 4M) and near the PP of the 3rd and 4th PA (black arrowheads in Fig. 10M). Additionally, 
weak expression of MAML1 was observed in the medial area of the limb (asterisk in Fig. 10N), 
somites (Fig. 10K and N) and neural tube (Fig. 10K and N). MAML1 sense probe showed faint 
hybridization signals in the hind-brain and otic vesicle (asterisk and arrowhead in Fig. 10O, 
respectively).  
 
 
IV.2.2. Expression of Notch signaling-related genes in the 3/4PP region (at E3 and E4) 
 
The expression of Notch1, MAML1, Hes5-1 and Hes6-1 genes was evaluated using the 
antisense probes for each gene, in E3 and E4 chicken embryos. By E3, we observed uniform 
hybridization signals of Notch1 (using ICN1 probe) in the mesenchymal territory surrounding 
the 3/4PP (Fig. 11B).  In E4 chicken embryos, hybridization signals were more restrict to the 
anterior domain of the 3/4PP (Fig. 11D) and mesenchyme of the 4th PA (Fig. 11D). MAML1 
expression was present in the territory surrounding the 3/4PP of E4 chicken embryos (Fig. 
11F).  
When we analyzed the expression of Notch target genes Hes5-1 and Hes6-1, we 
observed its presence in the 3/4PP region at the stages of development prior to thymic 
epithelium specification. In E3 chicken embryos, Hes5-1 showed a dotted expression in the 
mesenchyme surrounding the 3/4PP (Fig. 11H) and throughout the 3rd and 4th PA (Fig. 11H). 
By E4, Hes5-1 expression was observed in the 2nd and 3rd aortic arch artery (AA) (Fig. 11J) and 
in the anterior domain of the 3rd PP and 4th PP (Fig. 11J). In E3 chicken embryos, Hes6-1 was 
expressed in the 3/4PP, with stronger expression in the posterior domain of the 3rd PP and in the 
most ventral domain of the 4th PP (Fig. 11L). Some expression of Hes6-1 was also observed in 
the territory dorsally to the 3/4PP, the region of developing nodose ganglion (Fig. 11L). By E4, 
Hes6-1 continued to be expressed in the most dorsal/posterior domain of the 3/4PP and started 
to be expressed in the ventral/posterior domain of the 5th PP (Fig. 11N). Together, the data 
showed that Notch signaling receptor (Notch1), modulator (MAML1) and target genes (Hes5-1, 
Hes6-1) are expressed in the 3/4PP region of chick embryos at E3 and E4, suggesting a role 
of Notch signaling pathway in early stages of thymic development.  
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Figure 11. Expression of Notch signaling-related genes during early-stages of thymus development in 
the pharyngeal region of chicken embryos. Whole-mount in situ hybridization and corresponding schemes 
showing Notch1 (A-D), MAML1 (E-F),, Hes5-1 (G-J), and Hes6-1 (K-N), in the pharyngeal region of chicken 
embryos at E3 and E4. Arrow heads indicate the pharyngeal region structures which show expression of the 
genes under study. (AA, Aortic Arch; PA, Pharyngeal Arch; PP, Pharyngeal Pouch). Scale bars: 500 µm. 
 
IV.3. In vitro assays:  inhibition of Notch signaling in the pharyngeal region of 
the 3/4PP 
In parallel to in vivo studies, we developed a new in vitro experimental approach to 
study Notch signaling in early stages of thymic development. Organotypic cultures of the 
pharyngeal region explants of E3.5 and E4 embryos were performed in the presence of a 
pharmacological inhibitor (DAPT) of Notch signaling. After 48 h of culture, Hes5-1 and Hes6-
1 expression was analyzed in situ in E4 explants to evaluate Notch signaling inhibition. 
Furthermore, endoderm specification into thymic epithelium and maintenance of parathyroid 
domain in the cultured explants were analyzed by in situ expression of Foxn1 and Gcm2, 
respectively. Before culture, in situ hybridization of pharyngeal region explants of E4 embryos 
confirmed Notch1 (N=5/5) and Gcm2 (N=7/7) expression in the anterior domain of the 3/4PP 
endoderm (red and yellow arrow heads in Fig. 11B and C, respectively). Moreover, strong 
hybridization signals were also observed for Notch target genes, Hes5-1 (N=7/7, Fig. 12D) and 
Hes6-1 (N=8/8, Fig. 12G) in the 3/4PP. As previously reported (Hélia Neves et al., 2011 in 
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press), no Foxn1 expression was detected in the pouches at this stage of development (data not 
shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. Expression of Notch1, Gcm2, Hes5-1, Hes6-1 and Foxn1 in the ventral side of the pharyngeal 
region explants of E4 chicken embryos. A) Schematic representation of the dissection of the pharyngeal 
zone of E4 chicken embryo and ventral view of the dissected explant with Pharyngeal Arches (PA) and 
Pharyngeal Pouches (PP) identified. Expression of Notch1 (B), Gcm2 (C), Hes5-1 (D), and Hes6-1 (G) in 
dissected explants at day zero (d0). Expression of Hes5-1 (E) and Hes6-1 (H), Gcm2 (J) and Foxn1 (N) in 
pharyngeal explants cultured in control condition. Expression of Hes5-1 (F) and Hes6-1 (I) in pharyngeal 
explants cultured in the presence of 50 µM of DAPT. Scale of expression levels for Gcm2 (K-M) and Foxn1 
(O-R) in pharyngeal explants cultured in the presence of 50 µM of DAPT, compared with the expression 
patterns of pharyngeal explants cultured in control condition (J for Gcm2 and N for Foxn1). (A, Anterior; L, 
Left; P, Posterior; PA, Pharyngeal Arch; PP, Pharyngeal Pouch; R, Right). Scale bars: 500 µm. 
 
We began to assess the dose of DAPT capable of inhibit Notch signaling in the 
organotypic cultures. Explants were cultured in the presence of 25 µM and 50 µM of DAPT or 
without DAPT (control condition). After 48 h, E4 explanted tissues grown in the presence of 
DAPT were viable and had similar morphology to control explants. However, in all conditions 
it was observed a change in the shape of the pharyngeal region with less defined borders 
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(comparison between Fig. 12C and J). As no morphological differences were observed for all 
culture conditions, further studies were performed using the highest DAPT concentration (50 
µM), which revealed not to be toxic in other context of cell culture (ES cultures, personal 
communication Alcobia I.). E4 explants grown in the presence of DAPT showed no expression 
of Hes5-1 (N=7/7, Fig. 12F). Conversely, strong and dotted hybridization signals were 
observed in control conditions (N=5/5, Fig. 12E). When Hes6-1 expression was analyzed, a 
change in the pattern of expression was observed in explants grown with DAPT (Fig. 12I) 
when compared to control conditions (Fig. 12H). These results showed that, inhibition of Notch 
signaling with 50 µM of DAPT down-regulates the expression of Hes5-1 in pharyngeal 
explants. Conversely, a change of Hes6-1 expression pattern was observed in the same culture 
conditions. 
After establishing the conditions for Notch signaling inhibition, we analyzed the 
expression of Gcm2 and Foxn1 in the cultured explants. In all cultured explants, we observed a 
reduction in the size of the domain of Gcm2 expression (Fig. 12J, L and M) when compared to 
d0 (Fig. 12C). In addition, the majority of cultured explants showed only one pair of the 
domains of expression for Gcm2 (N=15/18, Fig. 12J, L and M) and Foxn1 (N=19/23, Fig. 12N, 
P-R) genes, instead of the expected two pairs.  
To evaluate the effects of Notch signaling inhibition in the expression of Gcm2 and 
Foxn1, a scale of expression levels was defined having control conditions as reference (Fig. 12J 
and N, respectively):  negative (no expression) (Fig. 12K and O), lower (than control, Fig. 12L 
and P), equal (to control, Fig. 12M and Q), and higher (than control, Fig. 12R).  
The majority of E3.5 explants grown in the presence of DAPT were negative for Gcm2 
expression (87.5%) and only 12.5% (N=1/8 explants) showed equal expression to control 
(N=9) (Table 3). In E4, 40% (N=4/10) of the explants were negative, 50% (N=5/10) showed 
lower expression and only 10% (N=1/10) of the explants showed equal expression to control 
(N=10) (Table 3). These results indicated that the inhibition of Notch signaling in the 
pharyngeal region blocks or reduces the expression of Gcm2 in the endoderm of the 3/4PP.  
 
 
Table 3 – Analysis of Gcm2 expression in pharyngeal explanted tissues grown in the presence of 50 µM of 
DAPT, in E3.5 and E4 developmental stages. 
 
 
 
 
 
 
 
When we analyzed Foxn1 expression we noticed a more heterogeneous effect of Notch 
inhibition. In E3.5 explants cultured in DAPT condition, 2/12 (16.7%) explants were negative, 
3/12 (25%) showed lower expression, 4/12 (33.3%) had equal expression and 3/12 (25%) 
showed higher expression than control (N=12) (Table 4). Similarly, in E4 explants, 1/11 (9.1%) 
was negative, 1/11 (9.1%) showed lower expression, 6/11 (54.5%) had equal expression and 
3/11 (27.3%) showed higher expression than control (N=10) (Table 4). These results showed no 
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clear effect on Foxn1 expression in the 3/4PP endoderm when Notch signaling is inhibited in 
the pharyngeal region. Even, with refinement of embryonic stages according to Hamburger and 
Hamilton (HH20-24, detailed in Tables 3 and 4), we were unable to clarify the heterogeneity of 
the observed results. 
 
Table 4 – Analysis of Foxn1 expression in pharyngeal explanted tissues grown in the presence of 50 µM of 
DAPT, in E3.5 and E4 developmental stages. 
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V. Discussion 
 
The main objective of this work was to study the role of Notch signaling in early stages 
of thymic development. For that, we developed in vivo and in vitro experimental approaches of 
gain and loss-of-function of Notch signaling.  
To modulate in vivo Notch signaling in a stable and cell-autonomous manner, two new 
vectors were produced with either the constitutively active form of Notch1 (ICN1) or the 
dominant-negative form of MAML1 (DNMAML1). Using in ovo electroporation assay, we 
showed that pT2K-DNMAML1eGFP construct in this system was able to block Notch 
signaling, whereas pT2K-ICN1eGFP still needs confirmation to its ability to constitutively 
activate Notch signaling. 
In vitro assays of the pharyngeal region were performed to study the effect of Notch 
signaling inhibition during epithelial-mesenchymal interactions at early of thymic/parathyroid 
development. A down-regulation of Gcm2 expression was observed in the cultured explants 
suggesting that Notch signaling is required in early-stages of parathyroid development. 
Although Notch signaling receptor (Notch1), modulator (MAML1) and target genes (Hes5-1, 
Hes6-1) are expressed in the 3/4PP region of chick embryos at E3 and E4, no clear evidences 
were obtained for the role of Notch signaling in TEC specification when using our in vitro 
assay.  
 
V.1. In vivo modulation of Notch signaling. Production of Notch Constructs: 
pT2K-ICN1eGFP (gain-of-function) and pT2K-DNMAML1eGFP (loss-of-function) 
To modulate Notch signaling in the prospective thymic epithelium compartment we aim 
to genetically modify 3/4PP endoderm using a combined system of transposon-mediated 
transgene and tetracycline-induced conditional expression (Sato et al., 2007; Watanabe et al., 
2007). We started to design and generate two new plasmids, pT2K-ICN1eGFP (gain-of-
function) and pT2K-DNMAML1eGFP (loss-of-function). These vectors were successfully 
obtained, as confirmed by sequencing analysis. In the next step, we tested the capacity of 
pT2K-ICN1eGFP and pT2K-DNMAML1eGFP to activate or inhibit Notch signaling, 
respectively. For that we used the classic C2C12 myoblast differentiation assay (Lindsell et al., 
1995). To genetically modify C2C12 cells we used two methods, electroporation and 
transfection (with FuGENE reagent). These two strategies showed low efficiency in genetically 
modifying C2C12 cells, therefore, a different approach was used. We decided to do in vivo 
functional assays by electroporation of the developing neural tube of the chicken embryo.  
In ovo neural tube electroporation is known to be an accessible procedure and it would 
be an easy in vivo approach with direct results. Moreover, the sequences of our notch constructs 
derive from Gallus gallus Notch1 and MAML1 genes making this a more suitable assay (as 
opposed to the murine C2C12 assay). We began these experiments with the pT2K-
DNMAML1eGFP combination of vectors, as the sequence of DNMAML1 (205bp) is much 
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smaller than the sequence of ICN1 (2417bp), and so, it would be expected to be easier to 
integrate in the genome. In fact, we were able to confirm the functionality of pT2K-
DNMAML1eGFP by the lack of Hes5-1 expression in the electroporated side of the neural tube 
(assessed by in situ hybridization). However, and surprisingly, this result was observed in the 
GFP negative embryos of the DNMAML1 condition (whereas the two GFP positive embryos 
of DNMAML1 condition showed no differential expression of Hes5-1). Although, co- 
expression of GFP and DNMAML1 is expected we may hypothesis a delay in GFP expression 
in relation to DNMAML1 expression, in some of the cases. Other hypothesis that we may 
envisage is the saturation of hybridization signals of the GFP positive embryos.  
As to the pT2K-ICN1eGFP construct, we were unable, until the moment to verify its 
functionality. Only one GFP negative embryo was obtained in ICN1 condition and it showed 
similar levels of Hes5-1 expression in both sides of the neural tube. It is important to notice that 
the electroporation with ICN1 condition was only performed once, and the embryos were not in 
good conditions (of development), which made the electroporation procedure more difficult. 
The combination of these factors led to a very low viability. In addition, and as mentioned 
above, ICN1 insert is 2417bp long (10x DNMAML1 size), making its genomic integration 
more difficult. To overcome these difficulties, we repeat the electroporation with the ICN1 
construct and assess its conditions for this vector. 
Also, there are some remarks regarding the electroporation procedure. The viability of 
electroporated embryos decreased over time, which was expected after aggressive manipulation 
of the embryos, as previously described (Sato et al., 2007).  However, the more drastic 
decreased occurred between 24h and 48h after electroporation in control and DNMAML1 
conditions [In the DNMAML1 condition, only 21 of the 38 of experimental embryos (Table 1) 
were monitored at 16-24h and 40-48h. We observed that 90.5% (19/21) and 57.9% (11/19) of 
electroporated embryos were alive at 16-24h and 40-48h, respectively.]. Therefore, some 
decreased of viability may be attributed to a kind of “checkpoint” during chicken development.  
Previous studies showed that GFP expression was expected at least 24h after 
electroporation and doxycycline administration (Sato et al., 2007). However, in our 
experiments, the emergence of GFP expression in control condition was asynchronous with 
only 50% of the embryos starting to express GFP at 16-24h after electroporation. Also, in the 
DNMAML1 experimental condition, GFP positive embryos were only detected at 40-48h post-
electroporation. As, similar percentage of GFP positive embryos were observed at 16-24h in 
control condition and at 40-48h in DNMAML1 condition, it suggests a 24 h delay of GFP 
expression when embryos are electroporated with the system of vectors containing DNMAML1 
construct. A hypothesis to explain this effect is a reduction in the efficiency of GFP 
transcription as the bicistronic promoter is also promoting DNMAML1 expression.  Finally, as 
no new GFP positive embryos were observed at 64-72h for any experimental condition, our 
results suggest that GFP expression occurs in the first 48h after electroporation.  
To increase the percentage of GFP positive electroporated embryos, increasing 
concentrations and latter administration of doxycycline will also be tested in the future. 
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V.2. Expression of Notch signaling related genes in chicken embryos at stages 
of development prior to thymic epithelium specification 
V.2.1. Expression of Notch1 and MAML1 in chick embryos at E3 and E4 
  
The pattern of Notch1 expression using the new antisense ICN1 probe was similar to 
those observed when using probes for other regions (or the full length) of Notch1 gene (at 
http://geisha.arizona.edu/geisha/index.jsp) at the two stages of development studied. As no 
hybridization signals were detected when using the sense ICN1 riboprobe, we concluded that 
the ICN1 probe is specific for Notch1 gene.  
As to the new probe for MAML1 gene, the MAML1 antisense probe revealed a very 
similar expression pattern at E4 to the one found in mouse at E9.5-10.5 (Lizi Wu et al., 2004) . 
The expression of MAML1 colocalized with the Notch1 expression in the cephalic vesicles, the 
optic and otic vesicle, as well as the limb. The presence of both mRNA in the same regions is in 
agreement with these genes coding for proteins belonging to Notch signaling transcriptional 
activation complex. Interestingly, in the limb of E4 chicken embryos, the expression of both 
genes does not colocalize. Notch1 expression is present in the distal portion of the limb 
(asterisk in Fig. 10I), whereas MAML1 is expressed in the medial area of the limb (asterisk in 
Fig. 10N). This suggests that at this stage the canonical pathway of Notch signaling may not be 
activated in the limb. Another hypothesis is that MAML1 is present in those regions working in 
other signaling pathways, as it is known that MAML1 proteins also have some regulatory 
functions in other signaling pathways, like Wnt signaling, for example(McElhinny, J.-L. Li, & 
L Wu, 2008). 
 
 
V.2.2. Expression of Notch signaling related genes in the 3/4PP region (E3 and E4) 
 
The presumptive territories of thymus and parathyroid glands in E4.5 chicken embryos 
have been shown to be distinct and contiguous domains of PP3/4, with Foxn1 in the dorsal 
domain and Gcm2 in the median/anterior domain of the epithelial pouches (Hélia Neves et al., 
2011 in press). The Notch signaling-related genes addressed in this work are expressed in the 
3/4PP region before thymus development. In E3, Notch1, and target genes Hes5-1 and Hes6-1 
are expressed in the surrounding mesenchyme of the 3/4PP (Fig. 11B, H and L), suggesting that 
Notch signaling is activated in this mesenchyme. In addition, the boundaries of 3/4PP express 
Notch1 (Fig. 11B) and the posterior domain of the 3rd PP and the ventral domain of the 4th PP 
express Hes6-1 (Fig. 11L). These data suggest a role of Notch signaling in thymic/parathyroid 
glands development, probably during epithelial-mesenchymal interactions prior to TEC 
development/specification. The assessment of MAML1 expression in E3 could add evidence for 
this hypothesis, so it should be studied at this stage. By E4, the 3/4PP starts to express all 
studied transcripts. MAML1 is expressed in the 3/4PP region (Fig. 11F), whereas Notch1 is 
restricted to their anterior domains (Fig. 11D). The posterior domain of 4th PP expresses Hes6-
1(Fig. 11N) and Hes5-1 (Fig. 11J) and the surrounding mesenchyme Notch1 and MAML1 (Fig. 
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11 D and F, respectively). In addition, at this stage both Notch targets genes are expressed in 
the emerging 5th PP endoderm (Fig. 11J and N) and Hes5-1 is also being expressed in the 3rd 
and 4th AA (Fig. 11J). Again, the presence of these Notch signaling-related genes in both 3/4PP 
endoderm and surrounding mesenchyme suggest a role for Notch signaling in 
thymus/parathyroid glands development. However, it is curious to observe that Hes6-1 
expression in the 3rd PP and Hes5-1 and Hes6-1 expression in the 4th PP are located in the 
posterior domain of the pouches (Fig. 11J and N). This domain seems to have no known fate, as 
neither Foxn1 nor Gcm2 are presented in it. This data suggest that Notch signaling in the 
posterior domain of the 3/4PP endoderm may regulate thymus/parathyroid development by 
restricting Foxn1 and Gcm2 expression domains. 
 
V.3. In vitro assays:  inhibition of Notch signaling in the pharyngeal region of 
the 3/4PP. 
While the in vivo assays for Notch signaling modulation were being developed, we 
performed in parallel in vitro assays. Explants of the pharyngeal region of E3.5 and E4 embryos 
were cultured in the presence of a pharmacological inhibitor of Notch signaling (DAPT) for 48 
h/60 h. Endoderm specification into thymic epithelium and maintenance of parathyroid domain 
of the cultured explants were assessed by in situ expression of Foxn1 and Gcm2. Embryonic 
day 4 was first chosen for dissection and culture of pharyngeal region explants, as it is half-day 
prior to Foxn1 detection (E4.5) (Hélia Neves et al., 2011 in press). Also, 48 h of culture seem to 
be the reasonable culture time that would allow conservation of the explant’s viability and the 
normal establishment of Foxn1 expression.  
The analysis of Hes5-1 expression in the explanted tissues confirmed the efficient 
Notch inhibition by DAPT (Fig. 12E). Moreover, the complete inhibition of Hes5-1 
expression/ablation of Hes5-1 expression further suggests that Hes5-1 is a direct target of the 
canonical Notch signaling pathway in the developing 3/4PP endoderm. It is interesting to 
observe that both in vivo and in vitro studies of inhibition/block of Notch signaling (by 
electroporation of DNMAML1 combination of vectors or by culture with DAPT) showed a 
decrease/ablation of Hes5-1 expression (Fig. 9III and IV), strongly supporting the hypothesis 
that Hes5-1 is a direct target of Notch signaling. On the other hand, Hes6-1 was not inhibited 
by γ-Secretase inhibition, suggesting it is not a direct target of the canonical Notch signaling 
pathway.  
A down-regulation of Gcm2 expression was observed in the E4 cultured explants grown 
in the presence of DAPT (Table 3), suggesting that Notch signaling is required in early-stages 
of parathyroid development. Accordingly, the results obtained with E3.5 explants supported 
this hypothesis, showing an even clearer trend for Gcm2 inhibition, with 87.5% of experimental 
explants showing negative Gcm2 expression compared to control (Table 3).  
Although it has been shown that Foxn1 and Notch signaling are mutually regulated 
during hair follicle development (Cai, Lee, Raphael Kopan, & Ma, 2009; Hu et al., 2010), we 
did not found clear evidences of Foxn1 regulation by Notch signaling during cellular 
interactions between the endoderm of the 3/4PP and surrounding mesenchyme (Table 4). 
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Similar data was obtained at E3.5 and E4 cultured explants in the presence of Notch inhibitor 
(DAPT condition) (Table 4). The expression of Foxn1 in half of explants in DAPT condition 
was similar to control.  The remaining explants had either higher or lower expression levels 
when compared to control (Table 4). The decreased of Foxn1 expression in DAPT condition 
differed to previous data where mice with loss-of-function of Shh showed increased domain of 
Foxn1 at the expense of Gcm2 domain (Grevellec, Graham, & Tucker, 2011). On the other 
hand, the increased expression of Foxn1 in DAPT condition was also unexpected when 
evaluating previous preliminary data where Foxn1 expression was down-regulated in the 3/4PP 
endoderm cultured with mesenchyme in the presence of DAPT (data not shown, H. Neves 
group). The fact that 3/4PP endoderm development was study at different stages may contribute 
to this apparent discrepancy obtained in these in vitro experiments.   
To unravel this puzzling data, more assays must be performed. One possibility is to 
dissect and culture explants at younger and older stages. Furthermore, the in vivo modulation of 
Notch signaling by the genetic modification of 3/4PP quail endoderm (generating the gain- and 
loss-of-function of Notch signaling) will help to clarify the in vitro data, and ultimately, the role 
of Notch signaling in the specification/development of TECs. 
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VI. Conclusion 
 
With this work, we have shown that our pT2K-DNMAML1eGFP construct integrated 
in the “Tol2-mediated gene transfer” and “Tetracycline-dependent conditional expression” 
combined system of vectors was able to block Notch signaling. Therefore, we are now able to 
study the loss-of-function of Notch signaling in the 3/4PP endoderm during TECs 
specification/development. Prior to the loss-of-function study, we will characterize the original 
system of vectors on the chick-quail chimera system: electroporation conditions, efficiency, 
percentage of chimeric thymus obtained, survival, and the time interval between the 
administration of Doxycycline and expression of GFP, dependent of the developmental stage.  
On the other hand, the reliability of pT2K-ICN1eGFP construct in this system still needs to be 
confirmed. Thus, electroporation of chicken embryos with the combination of vectors 
containing the pT2K-ICN1eGFP will be repeated using higher concentrations of Doxycycline 
and maybe with latter administration of Doxycycline. After this confirmation, and also after the 
characterization of the original system of vectors, we will have a fully functional vector system 
that allows stable integration and inducible gain and loss-of-function of Notch signaling in the 
chicken. This system will allow the study of Notch signaling not only in TECs 
specification/development, but also in other developmental processes in the chicken model. 
Also, we have shown that Notch signaling receptor (Notch1), modulator (MAML1) and 
target genes (Hes5-1, Hes6-1) are expressed in the 3/4PP region of chick embryos at stages 
prior to TECs specification suggesting a role for Notch signaling in TEC 
specification/development.. The assessment of MAML1 expression in E3 chicken embryos will 
complement the information already gathered from analysis of the patterns of expression of 
receptor and target genes in the 3/4PP region at that stage. 
 Our in vitro assays did not provide, until now, clear evidences for the role of Notch 
signaling in TECs specification/development. However, it provided evidences suggesting that 
Notch signaling is required in early-stages of parathyroid development. We will perform more 
assays to clarify our heterogeneous data for Foxn1 expression, dissecting and culturing 
pharyngeal explants at younger and older stages. Also, the gain- and loss-of-function studies 
mentioned above will help unravel our puzzling data. 
 
With the development of our in vivo and in vitro strategies, we expect to contribute for 
the unraveling of normal thymic development, a crucial step for understanding the events 
responsible for the maintenance of a healthy thymus function later in life, or for repairing its 
function in disease. Furthermore, this work may help to create new in vitro systems to generate 
T-cell repertoires thereby opening new opportunities to restore thymic function in athymic or 
immuno-compromised individuals, and improve organ transplantation therapies. 
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BUFFERS FOR MULTIPLE USES  
 
1X TAE  
EDTA (pH 8)                    1 mM  
Acetic acid                  20 mM  
Tris base                  40 mM  
 
PBS 1X  
NaCl                                            137 mM  
KCL                                               2.7 mM  
KCL                                               2.7 mM  
Na2HPO4                                     10 mM  
KH2PO4                                          2 mM  
Adjust pH to 7.4 with HCl  
 
PBT 0.1%  
Triton                                            0.1%                                    
PBS                              to final volume                 
 
 
BACTERIAL GROWTH  
 
Lysogeny Broth (LB) medium  
Tryptone                         1%  
Yeast extract                      0.5%  
NaCl                         1%  
 
LB agar 
7.5 g agar per 500 mL of LB medium  
 
 
SOLUTIONS FOR WHOLE MOUNT IN SITU HYBRIDIZATION 
 
3.7% Paraformaldehyde (PFA) in PBS  
7.4% Paraformaldehyde (stock)            1:2                                        
PBS                                                        1:2                   
 
PBT 0.1%  
Triton                                            0.1%                                    
PBS                              to final volume                 
 
 
 
 
 
50 
 
Hybridization Solution Stock Solution 100 mL 
50% Formamide  100% 50 mL 
1.3X SSC pH=5 20X 7.5 mL 
5 mM EDTA pH=8 500 mM 1 mL 
50 µg/ml Yeast RNA 20 mg/mL 250 µL 
0.2% Tween 20 100% 0.4 mL 
0.5% CHAPS 10% 5 mL 
100 µg/mL Heparine 50 mg/mL 0.2 mL 
H2O  35.65 mL 
 
 
 
MAB pH=7,5 Stock Solution 100 mL 
0.1 M Maleic Acid 2 M 5 mL 
0.15 M NaCl 5 M 3 mL 
NaOH 10 N 1.5+0.5 mL 
H2O  90 mL 
Adjust pH to 7.5 with NaOH 10N 
MABT: 0.1% Tween 20/MAB 
 
 
NTM pH=9.5 Stock Solution 100 mL 
0.1 M Tris pH=9.5 1 M 10 mL 
0.1 M NaCl 5 M  2 mL 
MgCl2 2 M 2.5 mL 
H2O  85.5 mL 
 
 
Ribopribes ICN1 DNMAML1 MAML1 
Sense linearized with EcoRV  
synthesized with SP6 
linearized with EcoRV  
synthesized with SP6 
linearized with HindIII  
synthesized with T7 
Antisense linearized with HindIII  
synthesized with T7 
linearized with HindIII  
synthesized with T7 
linearized with EcoRV  
synthesized with SP6 
Table 5. Restriction enzymes and RNA Polymerases used to generate ICN1, DNMAML1 and  
MAML1 sense and antisense riboprobes. 
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PREPARATION AND TRANSFORMATION OF COMPETENT DH5Α STRAIN OF 
E.COLI 
Non-competent bacterial cells from frozen glycerol stock were streak out onto LB plate and 
grown o.n.. Single colonies were selected for the starter culture with 3 mL of fresh LB without 
antibiotics and grown o.n. in a 37°C shaker (225 rpm).The next day 2 mL from the starter culture 
were diluted into 200 mL of fresh LB without antibiotics and incubated in a 37ºC shaker (225 rpm) 
for 3 h (until it reaches optical density at 600 nm (OD600) of 0.4–0.6). The culture was collected and 
put on ice (it is important to keep the cells and solutions on ice for the rest of the protocol). The 
cells were harvested at 4000 rpm for 5 min at 4ºC and the supernatant removed. After adding half of 
the initial volume of cold MgCl2 0.1 M, cells were harvested again and the supernatant removed 
again. Afterwards, it was added half of the initial volume of cold CaCl2 0.1 M and incubated on ice 
for 30 min. The cells were harvested again, the supernatant removed, and the pellet was 
resuspended in CaCl2 0.1 M/15% Glycerol to 1/15 of the original/initial volume. The final volume 
suspension was distributed in aliquots of 500 μL into 1.5 mL criotubes and stored at -80ºC. 
To transform DH5α cells, between 1-10 μL (15-20 μL from ligations) of circular plasmid 
DNA were incubated with 100-200 μL of competent bacteria (DH5α) for 20 min on ice. Then, they 
were exposed to a heat shock at 42ºC for 2 min followed by cooling on ice for 10 min. Next, 1 mL 
of LB medium was added and incubated in a 37°C shaker (225 rpm) for 45 min. Bacteria were 
plated (20-300 μL) on solid LB Agar medium containing ampicillin (100 μg/mL) (Sigma) and 
incubated o.n. at 37ºC to select the transformed bacteria. 
 
 
 
PHENOL: CHLOROFORM EXTRACTION AND PRECIPITATION WITH ETHANOL 
This step was performed to remove proteins from a nucleic acid solution. It was added 150 
μL of phenol: chloroform 1:1 (v/v) (Ambion) per sample and the lower phase (chloroform) was 
removed by pipetting with thin tips. After centrifuging at 11000 rpm for 5 min at 4ºC, the lower 
phase was removed again. Again, 150 μL of phenol: chloroform 1:1 (v/v) was added per sample, 
centrifuged at 11000 rpm for 10 min at 4ºC and then the lower phase removed. The aqueous phase, 
which contains nucleic acids, is the one that remains and 15 μL of sodium acetate (NaAC) 3 M and 
450 μL of absolute ethanol were added per sample. After the precipitation of the DNA by 
incubating at -80ºC for 30 min, the mixture was centrifuged at 13000 rpm for 30 min at 4ºC. The 
supernatant was removed and the pellet dried and resuspended in 10 μL of RNase-free water. 
 
 
 
WHOLE-MOUNT IN SITU HYBRIDIZATION PROTOCOL 
 
1. Dissect embryos in PBS and remove as much of the extra-embryonic membranes as possible. 
2. Fix the embryos in 3.7% Paraformaldehyde/PBS, leave in the roller for some time at room 
temperature and keep/store at 4°C o.n.. 
3. Wash two times in PBT (0.1% Tween-20/PBS) for 5 min (Roller). 
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4. Dehydration: 
4.1. Wash embryos in 50% Methanol/PBT for 5 min (Roller). 
4.2. Wash two times in 100% Methanol (Roller) for 5 min and store at -20°C o.n. (it can be 
stored up to one month). This o.n. incubation can be replaced by an incubation at -80ºC for 1-2h. 
 
5. Rehydrate embryos through Methanol series: 75%, 50%, 25% Methanol/PBT (Roller) for 5 min 
each. 
 
6. Wash two times in PBT (Roller). 
 
7. Permeabilize embryos with 20 μg/mL proteinase K in PBT (Roller) (1h30 and 2h for E3 and E4 
embryos, respectively). 
 
8. Transfer the permeabilized embryos directly to Post-Fixation solution: 3.7% Paraformaldehyde 
/0.1% Glutaraldehyde/PBT, for 20 min. 
 
9. Rinse and wash once with PBT for 5 min (Roller). 
 
10. Transfer the embryos to a proper/suitable hybridization tube. 
HYBRIDIZATION: 
11. Rinse once with 1:1 hybridization solution/PBT mix; rinse with 2 mL of new hybridization 
solution/PBT and let embryos settle. 
12. Rinse with hybridization solution. Rinse with 2 mL of new hybridization solution and let 
embryos settle. 
 
13. Replace with 1 mL hybridization solution and prehybridize at 70ºC for 2 h. 
 
14. Replace the hybridization solution by 1 mL of pre-warmed hybridization solution with 
≈400ng/mL of DIG-labeled RNA probe and hybridize at 70ºC o.n. 
 
POST-HYBRIDIZATION WASHES: 
15. Rinse twice with prewarmed (70°C) hybridization solution. 
16. Wash twice with prewarmed (70ºC) hybridization solution for 40 min. 
17. Wash with prewarmed (70ºC) hybridization solution: Maleic Acid Buffer (MABT) for 30 min. 
18. Rinse twice with MABT. 
 
19. Wash twice with MABT for 30 min. (Roller) 
 
IMUNO 
 
20. Block with 2% Boehringer Blocking Solution (BBS)/20% heat treated Fetal Bovine Serum 
(FBS)/MABT for 2 h (Roller). 
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21. Incubate with 1:2000 Anti-Digoxigenin-AP, Fab fragments antibody (Roche) in 2% BBS/20% 
FBS/MABT o.n.. 
 
POST-ANTIBODY WASHES AND REVELATION 
22. Rinse 3 times with MABT (Roller) for 1-2 h. In the second rinse, perforate cephalic vesicles of 
the embryos and transfer them to larger tubes. 
23. Wash with MABT for 2-3 days with a 12 h frequency (Roller). 
24. Wash twice with NTM for 10 min. 
 
25. Reveal with 0.45µL NBT (nitro blue tetrazolium chloride) + 3,5µL BCIP (5-bromo-4-chloro-3-
indolyl-phosphate)  in 1 mL NTM. Incubate at 37ºC protected from light. Follow regularly the 
revelation reaction. 
 
26. When color has developed to the desired extent, stop reaction by washing 3 times with PBT. 
Replace the PBT for PBS and store at 4ºC until acquisition of pictures. Store indefinitely in 3.7% 
PFA/PBS at 4ºC. 
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APPENDIX III – CODING SEQUENCES OF 
ICN1 and DNMAML1 
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In bold and underlined is an unresolved region of the sequence (the results showed constantly 
differences between the predicted chicken sequence and our sequencing results, so it was not 
possible to precise the correct sequence). 
ICN1 
 
GTGCTGGTGTCCCGCAAGCGGCGCAGGGAGCATGGCCAGCTCTGGTTCCCAGAGGGCTTCAAAGTGA
CGGAGTCGAGCAAGAAGAAGCGCCGGGAACCACTTGGGGAAGATTCTGTTGGACTGAAACCCCTCAA
AAATGCTTCTGACGGCACGCTGATGGACGACAACCAAAATGAGTGGGGTGACGAGGAGACCCTGGAC
ACCAAGAAGTTCAGGTTCGAGGAGCAGGCGATGCTGCCCGACACGGATGACCAGACGGACCACAGGC
AGTGGACTCAGCAGCACCTGGATGCTGCCGACCTCCGCATCTCCTCCATGGCCCCTACCCCACCACA
GGGCGAGATCGATGCAGACTGCATGGATGTCAACGTACGAGGTCCAGACGGCTTCACGCCCCTCATG
ATCGCCTCGTGCAGCGGAGGGGGGCTGGAGACTGGCAACAGCGAGGAGGAGGACGATGCCCCTGCAG
TCATCTCAGATTTCATCTACCAAGGCGCCAGTTTGCACAACCAGACTGACCGCACCGGCGAGACCGC
GCTGCACCTGGCTGCCCGCTACTCGCGCTCCGACGCTGCCAAACGCCTGCTGGAAGCCAGTGCTGAT
GCGAACATTCAGGATAACATGGGCAGGACCCCTCTGCACGCCGCTGTCTCTGCTGATGCCCAAGGAG
TCTTCCAGATCCTGATAAGGAACAGGGCGACTGATCTCGATGCCCGAATGCACGATGGGACGACCCC
ACTGATCCTGGCTGCTCGCTTGGCTGTGGAGGGGATGCTGGAGGACCTCATCAACTGCCACGCAGAC
GTCAACGCTGTGGATGATCTGGGCAAGTCAGCACTGCACTGGGCAGCTGCTGTGAACAATGTCGAAG
CCGCTGTCGTCCTCCTGAAGAACGGTGCCAATAAGGATATGCAGAACAATAAGGAGGAGACCCCGCT
GTTCCTCGCCGCCAGAGAAGGGAGCTACGAAACAGCCAAGGTTCTGCTGGACCACTTTGCGAACCGC
GACATCACGGACCACATGGACCGGCTGCCGCGGGACATCGCGCAGGAGCGCATGCACCACGACATCG
TGCGGCTGCTGGATGAGTACAACCTGGTGCGGAGCCCTCCGCTGCACAGCGGCCCTCTCGGGGCCCC
CACGCTGTCCCCCCCGCTCTGCTCCCCCAGCAGTTACATCGGCAACCTGAAGCCGGCCGTGCAGGGC
AAGAAGGCCAGGAAGCCGAGCACCAAGGGCCTGAGCTGCAACGGCAAGGATTCCAAAGACCTGAAAG
CCCGGAGGAAAAAATCACAAGATGGAAAAGGCTGTCTGCTCGACAACTCCAGCGTGCTGTCCCCAGT
GGACTCCCTGGAGTCACCCCACGGGTACCTGTCCGACGTCGCCTCCCCTCCGCTGATGACTTCTCCG
TTCCAGCAGTCCCCTTCCATGCCTCTGAACCACCTGCCTGGCATGCCCGACGCCCACATGAGCATCA
ACCACCTCAACATGGCAGGGAAGCAGGAGATGGCCCTGGGCGGCTCTGGCAGGATGGCCTTCGAGGC
GGTGCCGCCGCGCCTCTCGCACCTCCCCGTCTCCAGCCCCAGCACGGCGATGAGCAACGCCCCGATG
AATTTCTCCGTCGGCGGAGCTGCCGGCCTGAGCGGGCAGTGCGACTGGCTGAGCCGGCTGCAGAGCG
GCATGGTGCAGAACCAGTACGGCGCCATGCGGGGCGGCATGCAGCCGGGCACGCACCAGCAAGCACA
GAACCTGCAGCACGGCATGATGAGCTCCCTGCACAACGGGCTGCCCAGCACCAGCCTGTCGCAGATG
ATGAGCTACCAGGCCATGCCCAGCACCCGGCTGGCCTCCCAGCCCCACCTGCTGCAGAACCAGCAGA
TGCAGCAGATGCAGCAGCCCGGAATGCAGCCGCAGCCCGGAATGCAGCCGCAGCCCGGCATGCAGCA
GCCTCAACAGCAGCCCCAGCAACAGCCCCAGCCGCAGCAGCACCACAACCCCGGCTCCAACGCCAGC
GGCCACATGGGCCAAAATTTCCTCGGTACTGAGCTGAGCCAGCCCGACATGCAGCCGGTGAGCAGCA
GCGCCATGGCGGTGCACACCATCCTGCCCCAAGATTCGCAGCTGCTACCCACCTCTCTGCCGTCCTC
CCTCGCGCAGCCCATGACCACCACGCAGTTCCTGACCCCCCCTTCCCAGCACAGCTATTCCTCCCCG
TTGGACAACACCCCCAGCCACCAGCTCCAGGTGCCCGACCACCCCTTCCTCACTCCCTCTCCGGAGT
CTCCAGACCAGTGGTCGAGCTCCTCGCCCCACTCCAACGTGTCCGACTGGTCCGAGGGCATCTCCAG
CCCCCCCACCAGCATGCAGTCGCAGATGGGACACATCCCCGAGGCCTTCAAGTGA 
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Underlined are the nucleotides that did not match with the predicted chicken MAML1 sequence. The 
double underlined nucleotides result in three amino-acids that differ from the predicted chicken 
MAML1 sequence but are the same found in the mouse sequence, suggesting that the predicted 
chicken sequence might not be correct in that segment, and that the our sequence is real. 
DNMAML1 
 
GTGGTGCCGCGGCACAGCGCGGTGATGGAGCGGCTCCGTCGGCGCATCGAGCTCTGCC
GGCGGCACCACAGCGCCTGCGAGTCCCGCTACCAGGCCGTGTCCCCGGAGCGCCTGGA
GCTGGAGCGCCAGCAAACCTTCGCCCTGCACCAGCGCTGCCTGCAGGCCAAGGCCAAG
CGGGCCGGCAAGCAC 
 
